US11160746B2 - Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use - Google Patents

Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use Download PDF

Info

Publication number
US11160746B2
US11160746B2 US16/192,676 US201816192676A US11160746B2 US 11160746 B2 US11160746 B2 US 11160746B2 US 201816192676 A US201816192676 A US 201816192676A US 11160746 B2 US11160746 B2 US 11160746B2
Authority
US
United States
Prior art keywords
formulation
amount
present
hair
seed extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US16/192,676
Other versions
US20190183775A1 (en
Inventor
Iris Rubin
Gregory MAGED
John Garruto
Bethany McCARVER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clarity Cosmetics Inc
Original Assignee
Clarity Cosmetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clarity Cosmetics Inc filed Critical Clarity Cosmetics Inc
Priority to US16/192,676 priority Critical patent/US11160746B2/en
Publication of US20190183775A1 publication Critical patent/US20190183775A1/en
Priority to US16/739,774 priority patent/US10813872B2/en
Assigned to Clarity Cosmetics Inc. reassignment Clarity Cosmetics Inc. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CLARITY COSMETICS, LLC
Assigned to CLARITY COSMETICS, LLC reassignment CLARITY COSMETICS, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GARRUTO, JOHN, MAGED, Gregory, MCCARVER, Bethany, RUBIN, IRIS
Priority to US17/496,680 priority patent/US20220079865A1/en
Application granted granted Critical
Publication of US11160746B2 publication Critical patent/US11160746B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/737Galactomannans, e.g. guar; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/06Preparations for styling the hair, e.g. by temporary shaping or colouring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients

Definitions

  • those same hair products can migrate to the skin through various mechanisms.
  • the shampoo and conditioner unavoidably come into contact with the scalp, face, neck, chest, shoulders, and back, either through direct contact or as they are rinsed off and run down the skin in the shower.
  • Many hair care products including rinse off products, such as shampoos and conditioners, are also designed to leave a residue even after the product is subsequently rinsed out of the hair.
  • Leave in haircare products by design are not rinsed out and always leave a residue.
  • This residue may be good for the hair, but can often cause problems for the skin.
  • This residue can be deposited on the skin directly by direct contact with the skin on the scalp, and, for example, by dripping down from the hair to the face after application as well as when it runs down the person's face, neck, chest, shoulders, and/or back in the shower.
  • This residue can also be deposited on a person's skin indirectly, when an object successively comes into contact with the person's hair, and then their skin. For example, if the person dries their hair with a towel, the residue can be transferred to other parts of their body via the towel; residue may also be transferred from a person's hair to their face from a pillowcase.
  • hair care products are developed without consideration of the impact that the product will have on the user's skin, despite the fact that contact with the skin with each use is unavoidable.
  • Many hair care products can also build up on the skin or scalp over time, particularly if the hair care product is intended to be left in for days at a time; as a result, the hair care products may have a dramatically detrimental effect on the skin of a user.
  • Many hair care products also contain ingredients that can trigger irritation of the skin in some users.
  • hair and skin treatments may also have incompatible regimens; for example, a person with parched hair strands resulting from coloration of their hair, may require hair products with significant amounts of oils and conditioning agents, some of which can be comedogenic to the skin.
  • a “comedo” is an “acne lesion”, a hard blockage created from an excess of sebum combined with keratin (skin debris) in a pore which can lead to whiteheads, blackheads and pimples. Accordingly, the term, “comedogenic”, refers to ingredients or products that have a tendency to block pores and promote comedones or acne.
  • Those with curly and/or frizzy hair may use smoothing products that traditionally contain ingredients such as oils and conditioning agents that can be comedogenic, or can become comedogenic in combination with other ingredients.
  • ingredients such as oils and conditioning agents that can be comedogenic, or can become comedogenic in combination with other ingredients.
  • some common hair smoothing products such as some silicone hair smoothing products, have not been found to be significantly comedogenic on their own, but have been found to increase the penetration of other ingredients in a formulation, which may result in a more comedogenic product. This means that hair care products can, in many cases, contribute to and exacerbate skin conditions such as acne (or “acne vulgaris”), the most common skin disease in the United States.
  • Acne vulgaris affects up to 50 million people in the United States alone. Acne is not just a condition that affects teenagers. Acne is highly prevalent in adult women, with one study showing that 45% of women aged 21-30, 26% aged 31-40, and 12% aged 41-50 had clinical acne. Adult acne in women is also on the rise. According to the American Academy of Dermatology (AAD), acne can contribute to depression, anxiety, and poor self-image. It can also leave permanent scars.
  • AAD American Academy of Dermatology
  • Acne may arise when hair follicles (pilosebaceous units) become clogged.
  • Acne is characterized by comedones, clogged pores in the skin, which can either be open comedones (“blackheads”) or closed comedones (“whiteheads”).
  • Acne is also characterized by pimples, which can appear as inflammatory papules or pustules, cysts, or nodules.
  • Acne is caused by several major mechanisms: inflammation, oil/sebum, follicular hyperkeratinization, Propionibacterum acnes ( p. acnes ), a bacteria, and hormones.
  • Sebum an oily substance secreted by the sebaceous glands of the skin, can cause dead skin cells to stick together, which can clog pores and plug hair follicles, causing acne.
  • Sebum secretion has been correlated with acne severity, with high sebum secretion levels tended to be correlated with more severe acne; in some cases, a high sebum secretion rate may even be the decisive factor in inflammatory acne.
  • P. acnes is a bacteria that lives on the skin and can also get inside the follicle and contribute to inflammation, causing inflammatory acne lesions, including papules, cysts, and nodules.
  • Conventional belief was that all inflammatory acne lesions arose from comedones.
  • acne has been identified to be a primary inflammatory condition. There is evidence that inflammation plays a role at all stages of acne development, and can even be observed subclincally before the formation of comedones.
  • Acne can also be caused or exacerbated by certain cosmetics or styling products.
  • “Acne cosmetica” is a form of acne that is caused by or exacerbated by the use of certain cosmetic products, including, though not limited to, makeup and sunscreen.
  • “Acne cosmetica” typically results from a chemically-induced plugging of the hair follicles by these products.
  • Certain cosmetic products can also produce folliculitis, or inflammation of the hair follicle, which appears as small bumps on the skin that can be skin-colored, pink, or red, having an appearance similar to acne.
  • “pomade acne” is a similar condition to “acne cosmetica,” also resulting from chemically-induced plugging of the hair follicles, and characterized by bumps on the forehead caused by oily hair care styling products. This condition was originally described primarily in African American men. Both “acne cosmetica” and “pomade acne” may also be referred to generally as “acneiform eruptions.” Pomade acne has more recently been described as being an issue in all skin types, in both men and women due to hair products that smooth the hair, add shine, and reduce frizz. These products can contain oils, and waxes that clog pores, trap bacteria, and cause inflammation.
  • the ingredients in these hair products that clog pores and cause acne are not limited to oils and waxes used for styling and conditioning, as other ingredients can be problematic.
  • Comedogenic or potentially comedogenic components include PVP/DMAPA acrylates, cyclopentasiloxane, panthenol, dimethicone, some silicones (typically to a mild degree), Quaternium-70, oils, and petrolatum.
  • These ingredients may be comedogenic themselves, or, as mentioned previously, may enhance the comedogenicity, irritation, and/or allergic potential of other ingredients.
  • petrolatum itself is non-comedogenic, but is occlusive and can trap moisture and other ingredients in the hair follicles, causing stronger reactions to these ingredients.
  • the AAD recommends using personal care products, including hair care products, which have one of the following labels: “non-comedogenic,” “non-acnegenic,” “oil-free,” or “won't clog pores.”
  • these labels are not typically found on hair care products because hair care products are not typically formulated to be “non-comedogenic,” “non-acnegenic,” or “oil-free.”
  • oils that are or have the potential to be comedogenic.
  • other products such as silicones
  • Many leave-in products also contain significant quantities of these oils and silicones that can be comedogenic, including, though not limited to, styling creams, gels, pomades, hairsprays, smoothing serums, heat styling sprays, anti-frizz serums, heat-protectants, and shine sprays.
  • Other materials in hair care products are also potentially comedogenic.
  • a list of comedogenic or potentially comedogenic materials includes, but is not limited to, acetylated lanolin, acetylated lanolin alcohol, algin, almond oil, apricot kernel oil, avocado oil, grapeseed oil, bismuth oxychloride, butyl stearate, carrageenan, ceteareth 20, cetyl acetate, cocoa butter, coconut oil, coal tar, hydrogenated oils, D & C Red #17, D & C Red #21, D & C Red #3, D & C Red #30, D & C Red #36, decyl oleate, disodium oleamido peg-2 sulfosuccinate, lanolin, lanolin derivatives, ethylhexyl palmitate, glyceryl stearate SE, glyceryl-3-diisostearate, hexadecyl alcohol, hydrogenated vegetable oil, isocetyl alcohol, isocetyl
  • Occlusive agents can often contribute to comedogenicity and acne. See Fulton, J. Soc. Cosmet. Chem., 40, 321-333 (November/December 1989) “Comedogenicity and irritancy of commonly used ingredients in skin care products” for a discussion of comedogenic materials.
  • shampoos contain potentially irritating surfactants, such as sulfate-based surfactants; for example, sodium lauryl sulfate and ammonium lauryl sulfate are common surfactants that can cause irritation.
  • Irritation to the skin can produce folliculitis and small papules on the skin, which may appear similar to acne. The folliculitis that occurs is indistinguishable from acne to the majority of hair care product users. Irritation of the follicle can also increase penetration of other materials in the hair care product into the skin follicles, increasing the potential comedogenicity and acnegenicity of many materials that could come into contact with the skin, including other materials in the hair care product formulation.
  • Non-comedogenic and/or non-acnegenic hair care formulations may be disclosed.
  • the hair care formulation may be any kind of hair care product, including, for example, a shampoo, conditioner, or a styling product such as a styling spray, a hair spray, a shine enhancer, a root spray, a hair masque, a gel, or a styling cream, or some combination thereof.
  • a styling product such as a styling spray, a hair spray, a shine enhancer, a root spray, a hair masque, a gel, or a styling cream, or some combination thereof.
  • Such a formulation may allow for the cleaning, conditioning, and/or styling of the hair of a user without causing or promoting irritation or acne on the skin of the user.
  • Such a formulation may also help resolve skin irritation, breakouts, and/or acne.
  • the formulation may be used as part of a two-step method for washing hair.
  • a non-comedogenic and/or non-acnegenic shampoo is applied to cleanse the hair
  • a non-comedogenic and/or non-acnegenic hair conditioner may be applied.
  • certain hair care formulations that are non-comedogenic, or which are non-comedogenic and which do not tend to cause acne (non-acnegenic), may be disclosed.
  • such hair care formulations may prevent, improve, and/or alleviate acne, acneiform eruptions, folliculitis, pimples, blemishes, and/or skin breakouts.
  • hair care formulations may be used in isolation or as part of a regimen, as may be desired.
  • hair care formulations may be used in a multi-step shower method. This method may include, in step 1, applying shampoo; and, in step 2, applying conditioner.
  • hair care products may be used as part of a method for using a hair care formulation, or may be used independently, as desired. These products, or other products (such as shampoo, conditioner, and styling product) may be sold as part of a kit and designed to be compatible with or to complement one another, as may be desired.
  • an exemplary embodiment of a non-comedogenic or non-acnegenic hair care product may include a keratinolytic agent, an anti-inflammatory agent, a sebum modulator, and/or antimicrobial agents, as well as other ingredients or additives, as desired.
  • an anti-inflammatory agent may be added, but a keratinolytic agent, sebum modulator, or antimicrobial agent may not be added.
  • a keratinolytic agent, sebum modulator, or antimicrobial agent may not be added.
  • Other combinations may also be envisioned, as desired.
  • a keratinolytic agent may be added to the composition, and may, for example, be used to modulate and correct abnormal follicular keratinization. This may help to prevent obstruction of the hair follicle and subsequent bacterial overgrowth.
  • exemplary keratinolytic agents that may be used in the formulation include willowbark (salicin) or bakuchiol. In other exemplary embodiments, as discussed above, a keratinolytic agent may not be present.
  • an anti-inflammatory agent may be added to the composition and may, for example, be used to reduce skin inflammation, therefore preventing and/or improving acne lesions, including comedones, papules, cysts, and nodules.
  • exemplary anti-inflammatory agents that may be used in the formulation include bisabolol (an anti-inflammatory chamomile derivative), stearyl glycyrrhetinate, or grapefruit seed extract ( Citrus Grandis seed extract).
  • Exemplary anti-irritant agents that may be used in the formulation include pea protein.
  • a sebum modulator may be added to the composition and may, for example, be used to control the amount of sebum secreted by the sebaceous glands of the skin.
  • measures to decrease sebum have been shown to improve acne.
  • An exemplary embodiment of a formulation may make use of one or more topical sebum modulators, as desired.
  • Systemic retinoids including isotretinoin, reduce sebum, and are one of the most powerful acne treatments available, but generally must be administered orally; as such, an exemplary embodiment of a formulation may be formulated to be compatible with a simultaneous systemic retinoid treatment or other oral or topical acne treatment of a patient, if desired.
  • Exemplary sebum modulators that may be used in the formulation include Farnesyl Acetate, Panthenyl Triacetate, Tocopheryl Acetate, or grapefruit seed extract ( Citrus Grandis seed extract). In other exemplary embodiments, as discussed above, a sebum modulator may not be present.
  • An exemplary embodiment of a formulation may also be formulated to be compatible with a separate topical acne treatment regimen, if desired.
  • exemplary additives may be added for the purpose of protecting against pollution or protecting against ultraviolet light (UV), or for other purposes, as may be desired.
  • exemplary multifunction additives that may be added to the formulation include algae extract, juice pressed from blackcurrant, and raspberry leaves, butyl avocadate, zinc PCA, epilobium fleischeri extract, Laminaria Cloustoni extract, grapefruit seed extract ( Citrus Grandis seed extract), or Moringa oleifera seed extract (horse-radish tree).
  • no multifunction additives may be added to the formulation, as may be desired.
  • one or more high molecular weight ingredients may be added to the formulation.
  • a large constituent such as a polymer of polyethylene glycol (PEG) may be added to the formulation. This may serve to reduce the comedogenicity of the overall formulation.
  • PEG polyethylene glycol
  • one or more of a polar sugar or a heavy metal may be added to the formulation to reduce the comedogenicity of the overall formulation.
  • a polar sugar or a heavy metal may be added to the formulation.
  • zinc may be added to the formulation.
  • the degree of etholxylation of one or more of the molecules used in the formulation may be increased, or one or more ethoxylated materials may be added.
  • ingredients which are known to be comedogenic or which are potentially comedogenic may be excluded from the formulation.
  • the formulation may be oil-free, and free of laureth-4, isopropyl myristate and its analogs, lanolins, waxes, and certain conditioning agents, as well as other comedogenic or acnegenic compounds or compositions listed above or in a previous section. Occlusive agents, such as some of the above materials, can often contribute to comedogenicity and acne.
  • ingredients which are known to be irritating or potentially irritating, or ingredients that function as common allergens or which are not known to be hypoallergenic may also be excluded from the formulation.
  • the formulation may be sulfate-free.
  • ingredients that can exacerbate the comedogenic or acnegenic properties of another ingredient but which do not themselves have significant comedogenic or acnegenic properties such as silicone, may also be excluded.
  • a silicone substitute such as hemisqualane (a non comedogenic silicone substitute that has skin benefits) may be substituted for silicone in some quantity.
  • silicone or another ingredient that can exacerbate the comedogenic or acnegenic effects of another ingredient may be included, and the comedogenic and acnegenic properties of the formulation may be controlled by controlling other ingredients of the formulation instead.
  • ingredients which are known to be comedogenic or which are known to potentially be comedogenic when present in a formulation at a particular level may be kept below the level at which they are comedogenic.
  • a non-comedogenic conditioner may be provided by reducing but not eliminating the quantity of cetearyl alcohol present in a formulation; cetearyl alcohol may be comedogenic in high concentrations and minimally reactive at low concentrations.
  • the products will also be paraben-free, formaldehyde-free, and phthalate-free, or may not have any of those components in any significant quantities.
  • the pH of the formulation may be controlled at a desirable level, which may serve to reduce irritation and inflammation. It may be understood that the skin of a typical person is slightly acidic, typically having a pH of around 5.5 to 6.5, whereas many soaps, particularly bar soaps, may be formulated to have a pH that is slightly basic (around 8 to 9). This may cause skin irritation and inflammation. According to an exemplary embodiment, one or more acids may be added to the formulation such that the formulation has a pH that is neutral or slightly acidic, as desired.
  • different optimal ranges may be targeted for different non-comedogenic and/or non-acnegenic hair care formulations; for example, in an exemplary embodiment, the optimal pH of the shampoo may be 5.5-6.5 and the optimal pH of the conditioner may be 4.8-5.3. In other exemplary embodiments, pH may be controlled at another level, if desired; in other exemplary embodiments, no additives may be added to the composition in order to control pH.
  • the composition may also be formulated to have desirable qualities as a hair care product.
  • the composition may be rinseable and designed to leave only skin-friendly residue when rinsed. This may further minimize the potential for irritation or comedogenicity from the product.
  • the rinseability of the product may also provide other benefits, such as other benefits to the skin, such as may be desired.
  • the composition may be formulated to be color-safe or may otherwise be formulated to have minimal impact on color-treated hair.
  • variations of the composition may be formulated for use in specialized hair care products.
  • stratification between said hair care products may be based on hair type, benefit, or intended customer.
  • variations of an exemplary composition may be prepared specifically for and marketed at women, men, teens, and others.
  • variations of an exemplary composition may be prepared specifically for curly hair, damaged hair, dry hair, fine or flat hair, as well as more typical or normal hair.
  • variations of an exemplary composition may be prepared specifically for anti-frizzing, for promoting shine, for smoothing hair, for strengthening hair, or for any other purposes as may be desired.
  • An exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 1 and may be made by combining the following components in the proportions stated below.
  • the hair care product in table 1 may be used as a shampoo.
  • Non-Comedogenic/Acnegenic Shampoo Exemplary Compositions Ingredient Broad % Preferred Part A Water 10.0-70.0 20.0-40.0 Disodium EDTA 0.00-1.00 0.01-0.20 Part B Glycerin 0.00-10.0 0.01-3.00 Guar Hydroxypropyltrimonium chloride 0.05-5.00 0.01-0.50 Part C Citric acid 0.00-2.00 0.01-1.00 Part D Phenoxyethanol 0.01-1.00 0.01-1.00 Ethylhexylglycerin 0.01-1.00 0.01-0.50 Polyquaternium-7 0.50-10.0 0.50-5.00 Sodium lauroyl methyl isethionate 10.0-70.0 30.0-60.0 Cocamidopropylamine oxide 1.00-20.0 5.00-10.0 Glycol distearate 0.00-10.0 0.50-1.00 Part E Water 0.00-8.00 2.00-8.00 Acrylates copolymer 1.00-15.0 2.00-6.00 Part F C13-C15 alkane 0.01-10.0 0.01-1.50 Bisabolol 0.01-1.00
  • an exemplary formulation of hair care product may include phenoxyethanol and ethylhexylglycerin as separate components rather than including Euxyl PE 9010. This may allow the component chemicals (such as, again, phenoxyethanol and ethylhexylglycerin) to be provided in different proportions than are found in the chemical composition provided under the trade name.
  • acrylates copolymer listed in table 1 may be that sold under the trade name, Carbopol Aqua SF-1; however, it will be understood by those skilled in the art that any suitable lightly cross-linked rheology modifying acrylate copolymer may be employed in the practice of the invention.
  • an exemplary hair care product formulation of table 1 may be prepared according to the following process or a process similar to the following.
  • a sanitized mixing vessel may be prepared, and a quantity of deionized water may be added to the sanitized mixing vessel.
  • the remaining components of Part A which in the exemplary case shown in table 2 may be Disodium EDTA, may then be mixed into the mixing vessel.
  • the ingredients of part B may be premixed and may then be added to the batch.
  • the ingredients may be mixed into the batch until the batch is uniform.
  • the ingredients of part C may then be added to the combined batch, and again mixed until the resulting batch is completely smooth.
  • the combined parts A, B, and C may then be heated.
  • the combined batch may be heated to a temperature within a range of 60 to 65° C.
  • Part D The ingredients of Part D may then be added.
  • the resulting batch may be mixed until all solids are melted and the batch is uniform. Once the batch has been fully mixed, the batch may be cooled to a temperature within a range of 40 to 45° C.
  • the parts of part E may be added.
  • the components of part E may be pre-mixed prior to addition, which may be done, for example, concurrently with another step preceding the addition of components in part E.
  • the resulting batch may be mixed until uniform.
  • the ingredients of part F may be added, and likewise mixed until uniform.
  • the batch may then be cooled to a temperature of approximately 35° C.
  • the pH of the batch may at this time be adjusted to a pH within a range of 6.50 to 6.75.
  • the resulting composition may be a hair care product having the appearance of semi-viscous pearlized gel.
  • the color may be pearlescent white to off-white, which may in some exemplary embodiments be adjusted if desired.
  • the odor may be characteristic of the fragrance added to the composition; in some exemplary embodiments, the fragrance may be reduced or left out of the composition in order to produce an odorless composition.
  • the composition may have a pH at 25° C. of between 6.5 and 7.0, a viscosity at 25° C. (RVT), at spindle 5 at 20 rpm, of between 1000 and 12,000 cPs, and a specific gravity at 25° C. of between 0.98 and 1.03.
  • the composition may be kept to a low level of viable bacterial or fungal cells or other colony-forming units (CFU), of approximately ⁇ 10 CFU/g; the composition may also be kept free of pathogens.
  • CFU colony-forming units
  • one or more small-scale batches such as lab or pilot batches, may be made prior to large-scale manufacturing. Adjustments may be made to the production process based on, for example, the results of a batch made in a particular production environment.
  • FIG. 2 Another exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 2 and may be made by combining the following components in the proportions stated below.
  • the hair care product in table 2 may be used as a hair conditioner.
  • Non-Comedogenic/Acnegenic Hair Conditioner Exemplary Ingredient Broad % Preferred % Part A Water 50.0-90.0 60.0-90.0 Disodium EDTA 0.00-1.00 0.01-0.10 Phenoxyethanol 0.10-5.00 0.75-1.25 Ethylhexylglycerin 0.10-2.00 0.10-0.50 Citric acid 0.01-1.00 0.01-0.50 Stearamidopropyl dimethylamine 1.00-10.0 1.00-2.50 Polysorbate 80 0.00-5.00 0.10-1.00 Part B Cetearyl alcohol 0.50-10.0 1.00-5.00 Behentrimonium chloride 0.10-5.00 0.50-3.00 Cetyl palmitate 0.50-5.00 1.00-4.00 C13-C15 alkane 0.50-15.0 2.00-7.00 Shea butter cetyl esters 0.10-8.00 0.50-2.00 Part C Glycerin 0.00-10.0 0.10-2.00 Bisabolol 0.01-1.00 0.01-0.50 Fragrance 0.00-5.00 0.50-2.00
  • an exemplary hair care product formulation of table 2 may be prepared according to the following process or a process similar to the following.
  • a sanitized mixing vessel may be prepared, and a quantity of deionized water may be added to the sanitized mixing vessel. This DI water may then be heated to a temperature within the ranges of 80 to 85° C.
  • the remaining components of Part A may then be mixed into the mixing vessel.
  • the remaining components of Part A may be added in an order or sequence, which may for example be the order in which they are shown in the table.
  • the ingredients may be added only once the previous ingredient has been fully dissolved.
  • the phenoxyethanol of part A may be added, mixed until fully dissolved, and only then will the ethylhexylglycerin of part B be added.
  • the components of part B may be combined in a separate mixing vessel.
  • the components of part B may be heated to a temperature in the range of 80 to 85° C. after combination, and may then be mixed until uniform.
  • the components of part B may then be combined with the components of part A, for example by adding the components of part B to the mixing vessel of part A.
  • the resulting batch may then be mixed until it is smooth and uniform.
  • the batch may then be cooled to a temperature within the range of 35 to 40° C.; according to an exemplary embodiment, mixing may be continued during this cooling process.
  • the ingredients of part C may then be added to the combined batch of parts A and B.
  • ingredients may be added alone or in combination, as may be desired.
  • the resulting batch may be mixed until uniform; following this, it may continue to be mixed and may be cooled (for example by ambient temperature) until the temperature of the batch reaches a temperature between 30 and 35° C.
  • the resulting composition may be a hair care product having the appearance of viscous cream.
  • the color may be white to off-white, which may in some exemplary embodiments be adjusted if desired.
  • the odor may be characteristic of the fragrance added to the composition; in some exemplary embodiments, the fragrance may be reduced or left out of the composition in order to produce an odorless composition.
  • the composition may have a pH at 25° C. of between 3.8 and 5.5 a viscosity at 25° C. (RVT), at spindle 5 at 20 rpm, of between 2000 and 30,000 cPs, and a specific gravity at 25° C. of between 0.98 and 1.03.
  • the composition may be kept to a low level of viable bacterial or fungal cells or other colony-forming units (CFU), of approximately ⁇ 10 CFU/g; the composition may also be kept free of pathogens.
  • CFU colony-forming units
  • FIG. 3 Another exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 3 and may be made by combining the following components in the proportions stated below.
  • the hair care product in table 3 may be used as a curly styling cream.
  • an exemplary hair care product formulation of table 3 may be prepared according to the following process or a process similar to the following.
  • a sanitized mixing vessel add disodium EDTA and water from Part A. Begin heating to 75-80° C. while mixing. Add remaining ingredients of Part A. Mix with heat until clear and all solids are dissolved.
  • a separate vessel combine ingredients in Part B. Heat Part B to 75-80° C. and mix until uniform. Add Part B to Part A and mix until smooth and uniform. Add Part C to batch, mix until uniform and cool to 35-40° C. Add ingredients in Part D and mix until uniform. Continue mixing batch until temperate reaches 30-35° C.
  • the product has the appearance of a white viscous cream with a pH@ 25° C.: 3.8-4.2; viscosity @ 25° C. (RVT): Spindle 5, 20 RPM 4,000-8,000 cPs; specific gravity @ 25° C.: 0.98-1.03; microbiology ⁇ 10 CFU/g, No pathogens
  • FIG. 4 Another exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 4 and may be made by combining the following components in the proportions stated below.
  • the hair care product in table 4 may be used as a blow dry styling cream.
  • an exemplary hair care product formulation of table 4 may be prepared according to the following process or a process similar to the following.
  • a sanitized mixing vessel add disodium EDTA and water from Part A. Begin heating to 75-80° C. while mixing. Add remaining ingredients of Part A. Mix with heat until clear and all solids are dissolved.
  • a separate vessel combine ingredients in Part B. Heat Part B to 75-80° C. and mix until uniform. Add Part B to Part A and mix until smooth and uniform. Continue mixing and cool to 35-40° C. Add ingredients in Part C and mix until uniform. Continue mixing batch until temperate reaches 30-35° C.
  • the product has the appearance of a white viscous cream with a pH@ 25° C.: 3.8-4.2; viscosity @ 25° C. (RVT): Spindle 5, 20 RPM 3,000-8,000 cPs; specific gravity @ 25° C.: 0.98-1.03; microbiology ⁇ 10 CFU/g, No pathogens
  • one or more small-scale batches such as lab or pilot batches, may be made prior to large-scale manufacturing. Adjustments may be made to the production process based on, for example, the results of a batch made in a particular production environment.
  • compositions may also be envisioned, for example for other compositions of shampoos or conditioners or for other types of hair care products, such as styling gels or even combined shampoos and conditioners.
  • some embodiments may have relative compositions different from those shown; an exemplary composition may have a higher weight percent of one component chemical and a lower weight percent of a second component chemical.
  • Equivalent or substantially equivalent component chemicals may also be substituted for chemicals within a composition. Appropriate substitutions may be appreciated by one of skill in the art.

Abstract

An improved hair and scalp treatment composition comprising a hair care product wherein the improvement comprises reducing the comedogenicity thereof by excluding therefrom comedogenic elements having a Fulton scale grade greater than 2.

Description

CROSS REFERENCE TO RELATED APPLICATION
This application is a continuation of U.S. patent application Ser. No. 15/957,238, filed Apr. 19, 2018, now issued as U.S. Pat. No. 10,159,637, which is a continuation of U.S. patent application Ser. No. 15/618,420, filed Jun. 9, 2017, now issued as U.S. Pat. No. 9,949,915 which claims the benefit of Provisional U.S. Patent Application No. 62/348,510, filed Jun. 10, 2016, the entire contents and disclosure of which, both express and implied, are incorporated herein by reference.
BACKGROUND
When a person uses hair products on their hair, those same hair products can migrate to the skin through various mechanisms. For example, when shampooing and/or conditioning hair, the shampoo and conditioner unavoidably come into contact with the scalp, face, neck, chest, shoulders, and back, either through direct contact or as they are rinsed off and run down the skin in the shower.
Many hair care products, including rinse off products, such as shampoos and conditioners, are also designed to leave a residue even after the product is subsequently rinsed out of the hair. Leave in haircare products by design are not rinsed out and always leave a residue. This residue may be good for the hair, but can often cause problems for the skin. This residue can be deposited on the skin directly by direct contact with the skin on the scalp, and, for example, by dripping down from the hair to the face after application as well as when it runs down the person's face, neck, chest, shoulders, and/or back in the shower. This residue can also be deposited on a person's skin indirectly, when an object successively comes into contact with the person's hair, and then their skin. For example, if the person dries their hair with a towel, the residue can be transferred to other parts of their body via the towel; residue may also be transferred from a person's hair to their face from a pillowcase.
Most hair care products are developed without consideration of the impact that the product will have on the user's skin, despite the fact that contact with the skin with each use is unavoidable. Many hair care products can also build up on the skin or scalp over time, particularly if the hair care product is intended to be left in for days at a time; as a result, the hair care products may have a dramatically detrimental effect on the skin of a user. Many hair care products also contain ingredients that can trigger irritation of the skin in some users. In some cases, hair and skin treatments may also have incompatible regimens; for example, a person with parched hair strands resulting from coloration of their hair, may require hair products with significant amounts of oils and conditioning agents, some of which can be comedogenic to the skin.
According to the American Academy of Dermatology [AAD], a “comedo” is an “acne lesion”, a hard blockage created from an excess of sebum combined with keratin (skin debris) in a pore which can lead to whiteheads, blackheads and pimples. Accordingly, the term, “comedogenic”, refers to ingredients or products that have a tendency to block pores and promote comedones or acne.
Those with curly and/or frizzy hair may use smoothing products that traditionally contain ingredients such as oils and conditioning agents that can be comedogenic, or can become comedogenic in combination with other ingredients. For example, some common hair smoothing products, such as some silicone hair smoothing products, have not been found to be significantly comedogenic on their own, but have been found to increase the penetration of other ingredients in a formulation, which may result in a more comedogenic product. This means that hair care products can, in many cases, contribute to and exacerbate skin conditions such as acne (or “acne vulgaris”), the most common skin disease in the United States.
Acne vulgaris affects up to 50 million people in the United States alone. Acne is not just a condition that affects teenagers. Acne is highly prevalent in adult women, with one study showing that 45% of women aged 21-30, 26% aged 31-40, and 12% aged 41-50 had clinical acne. Adult acne in women is also on the rise. According to the American Academy of Dermatology (AAD), acne can contribute to depression, anxiety, and poor self-image. It can also leave permanent scars.
Acne may arise when hair follicles (pilosebaceous units) become clogged. Acne is characterized by comedones, clogged pores in the skin, which can either be open comedones (“blackheads”) or closed comedones (“whiteheads”). Acne is also characterized by pimples, which can appear as inflammatory papules or pustules, cysts, or nodules.
Acne is caused by several major mechanisms: inflammation, oil/sebum, follicular hyperkeratinization, Propionibacterum acnes (p. acnes), a bacteria, and hormones. Sebum, an oily substance secreted by the sebaceous glands of the skin, can cause dead skin cells to stick together, which can clog pores and plug hair follicles, causing acne. Sebum secretion has been correlated with acne severity, with high sebum secretion levels tended to be correlated with more severe acne; in some cases, a high sebum secretion rate may even be the decisive factor in inflammatory acne.
P. acnes is a bacteria that lives on the skin and can also get inside the follicle and contribute to inflammation, causing inflammatory acne lesions, including papules, cysts, and nodules. Conventional belief was that all inflammatory acne lesions arose from comedones. Recently, acne has been identified to be a primary inflammatory condition. There is evidence that inflammation plays a role at all stages of acne development, and can even be observed subclincally before the formation of comedones.
Acne can also be caused or exacerbated by certain cosmetics or styling products. “Acne cosmetica” is a form of acne that is caused by or exacerbated by the use of certain cosmetic products, including, though not limited to, makeup and sunscreen. “Acne cosmetica” typically results from a chemically-induced plugging of the hair follicles by these products. Certain cosmetic products can also produce folliculitis, or inflammation of the hair follicle, which appears as small bumps on the skin that can be skin-colored, pink, or red, having an appearance similar to acne.
For example, “pomade acne” is a similar condition to “acne cosmetica,” also resulting from chemically-induced plugging of the hair follicles, and characterized by bumps on the forehead caused by oily hair care styling products. This condition was originally described primarily in African American men. Both “acne cosmetica” and “pomade acne” may also be referred to generally as “acneiform eruptions.” Pomade acne has more recently been described as being an issue in all skin types, in both men and women due to hair products that smooth the hair, add shine, and reduce frizz. These products can contain oils, and waxes that clog pores, trap bacteria, and cause inflammation. Users of these products may find that these products are transferred to their pillow at night if left in their hair; as a result, users of these products may find that their faces are rolling around in oily, waxy, hair products all night. (Other hair products, particularly products not designed to be washed out within a day or so, may also cause similar problems.)
The ingredients in these hair products that clog pores and cause acne are not limited to oils and waxes used for styling and conditioning, as other ingredients can be problematic. Comedogenic or potentially comedogenic components include PVP/DMAPA acrylates, cyclopentasiloxane, panthenol, dimethicone, some silicones (typically to a mild degree), Quaternium-70, oils, and petrolatum. These ingredients may be comedogenic themselves, or, as mentioned previously, may enhance the comedogenicity, irritation, and/or allergic potential of other ingredients. For example, petrolatum itself is non-comedogenic, but is occlusive and can trap moisture and other ingredients in the hair follicles, causing stronger reactions to these ingredients.
For patients with adult acne, the AAD recommends using personal care products, including hair care products, which have one of the following labels: “non-comedogenic,” “non-acnegenic,” “oil-free,” or “won't clog pores.” However, these labels are not typically found on hair care products because hair care products are not typically formulated to be “non-comedogenic,” “non-acnegenic,” or “oil-free.” Currently, it is not standard to test hair care products for comedogenicity or acnegenicity, or to have oil-free hair care products for acne-prone skin. In fact, there is a trend in the beauty industry to add oils to hair care products.
Many common hair care products, such as shampoos, conditioners, and other hair care products, contain oils that are or have the potential to be comedogenic. As mentioned, other products, such as silicones, can also be comedogenic in combination with other products in a formulation. Many leave-in products also contain significant quantities of these oils and silicones that can be comedogenic, including, though not limited to, styling creams, gels, pomades, hairsprays, smoothing serums, heat styling sprays, anti-frizz serums, heat-protectants, and shine sprays. Other materials in hair care products are also potentially comedogenic.
A list of comedogenic or potentially comedogenic materials includes, but is not limited to, acetylated lanolin, acetylated lanolin alcohol, algin, almond oil, apricot kernel oil, avocado oil, grapeseed oil, bismuth oxychloride, butyl stearate, carrageenan, ceteareth 20, cetyl acetate, cocoa butter, coconut oil, coal tar, hydrogenated oils, D & C Red #17, D & C Red #21, D & C Red #3, D & C Red #30, D & C Red #36, decyl oleate, disodium oleamido peg-2 sulfosuccinate, lanolin, lanolin derivatives, ethylhexyl palmitate, glyceryl stearate SE, glyceryl-3-diisostearate, hexadecyl alcohol, hydrogenated vegetable oil, isocetyl alcohol, isocetyl stearate, isodecyl oleate, isopropyl isostearate, isopropyl myristate, isopropyl palmitate, isostearyl isostearate, isostearyl neopentanoate, laureth-23, laureth-4, lauric acid, mink oil, myristic acid, myristyl lactate, myristyl myristate, octyl palmitate, octyl stearate, oleic acid, oleates, oleth-3, oleyl alcohol, olive oil, peg 200 dilaurate, PEG 8 stearate, PG monostearate, PPG 2 myristyl propionate, polyglyceryl-3-diisostearate, propylene glycol monostearate, sesame oil, sodium laureth sulfate, sodium lauryl sulfate, sorbitan oleate, soybean oil, steareth 10, stearyl heptanoate, sulfated oils, triethanolamine, wheat germ glyceride, wheat germ oil, and certain conditioning agents. Occlusive agents, including some of the above materials, can often contribute to comedogenicity and acne. See Fulton, J. Soc. Cosmet. Chem., 40, 321-333 (November/December 1989) “Comedogenicity and irritancy of commonly used ingredients in skin care products” for a discussion of comedogenic materials.
In addition, most shampoos contain potentially irritating surfactants, such as sulfate-based surfactants; for example, sodium lauryl sulfate and ammonium lauryl sulfate are common surfactants that can cause irritation. Irritation to the skin can produce folliculitis and small papules on the skin, which may appear similar to acne. The folliculitis that occurs is indistinguishable from acne to the majority of hair care product users. Irritation of the follicle can also increase penetration of other materials in the hair care product into the skin follicles, increasing the potential comedogenicity and acnegenicity of many materials that could come into contact with the skin, including other materials in the hair care product formulation.
SUMMARY
Non-comedogenic and/or non-acnegenic hair care formulations may be disclosed. In some embodiments, the hair care formulation may be any kind of hair care product, including, for example, a shampoo, conditioner, or a styling product such as a styling spray, a hair spray, a shine enhancer, a root spray, a hair masque, a gel, or a styling cream, or some combination thereof. Such a formulation may allow for the cleaning, conditioning, and/or styling of the hair of a user without causing or promoting irritation or acne on the skin of the user. Such a formulation may also help resolve skin irritation, breakouts, and/or acne.
In an exemplary embodiment, the formulation may be used as part of a two-step method for washing hair. In the first step, a non-comedogenic and/or non-acnegenic shampoo is applied to cleanse the hair, and, in the second step, a non-comedogenic and/or non-acnegenic hair conditioner may be applied.
DETAILED DESCRIPTION OF THE EMBODIMENTS
Aspects of the invention are disclosed in the following description and related drawings directed to specific embodiments of the invention. Alternate embodiments may be devised without departing from the spirit or the scope of the invention. Additionally, well-known elements of exemplary embodiments of the invention will not be described in detail or will be omitted so as not to obscure the relevant details of the invention. Further, to facilitate an understanding of the description discussion of several terms used herein follows.
The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any embodiment described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other embodiments. Likewise, the term “embodiments of the invention” does not require that all embodiments of the invention include the discussed feature, advantage or mode of operation.
According to an exemplary embodiment, certain hair care formulations that are non-comedogenic, or which are non-comedogenic and which do not tend to cause acne (non-acnegenic), may be disclosed. In some exemplary embodiments, such hair care formulations may prevent, improve, and/or alleviate acne, acneiform eruptions, folliculitis, pimples, blemishes, and/or skin breakouts.
According to another exemplary embodiment, methods for using the hair care formulations may be described. Such methods may be used in isolation or as part of a regimen, as may be desired. For example, in an exemplary embodiment, hair care formulations may be used in a multi-step shower method. This method may include, in step 1, applying shampoo; and, in step 2, applying conditioner. In some exemplary embodiments, hair care products may be used as part of a method for using a hair care formulation, or may be used independently, as desired. These products, or other products (such as shampoo, conditioner, and styling product) may be sold as part of a kit and designed to be compatible with or to complement one another, as may be desired.
As mentioned, a variety of causes for acne can exist, including follicular hyperkeratinization (keratinocytes stick together and block the pore), inflammation, sebum, Propionibacterium acnes, hormones, and other factors. Therefore, an exemplary embodiment of a non-comedogenic or non-acnegenic hair care product may include a keratinolytic agent, an anti-inflammatory agent, a sebum modulator, and/or antimicrobial agents, as well as other ingredients or additives, as desired. In some exemplary formulations, only one or more of the above components may be added; for example, in an exemplary embodiment, an anti-inflammatory agent may be added, but a keratinolytic agent, sebum modulator, or antimicrobial agent may not be added. Other combinations may also be envisioned, as desired.
According to an exemplary embodiment, a keratinolytic agent may be added to the composition, and may, for example, be used to modulate and correct abnormal follicular keratinization. This may help to prevent obstruction of the hair follicle and subsequent bacterial overgrowth. Exemplary keratinolytic agents that may be used in the formulation include willowbark (salicin) or bakuchiol. In other exemplary embodiments, as discussed above, a keratinolytic agent may not be present.
According to an exemplary embodiment, an anti-inflammatory agent may be added to the composition and may, for example, be used to reduce skin inflammation, therefore preventing and/or improving acne lesions, including comedones, papules, cysts, and nodules. Exemplary anti-inflammatory agents that may be used in the formulation include bisabolol (an anti-inflammatory chamomile derivative), stearyl glycyrrhetinate, or grapefruit seed extract (Citrus Grandis seed extract). Exemplary anti-irritant agents that may be used in the formulation include pea protein.
According to an exemplary embodiment, a sebum modulator may be added to the composition and may, for example, be used to control the amount of sebum secreted by the sebaceous glands of the skin. Clinically, measures to decrease sebum have been shown to improve acne. For example, both systemic and topical treatments may be available. An exemplary embodiment of a formulation may make use of one or more topical sebum modulators, as desired. Systemic retinoids, including isotretinoin, reduce sebum, and are one of the most powerful acne treatments available, but generally must be administered orally; as such, an exemplary embodiment of a formulation may be formulated to be compatible with a simultaneous systemic retinoid treatment or other oral or topical acne treatment of a patient, if desired. Exemplary sebum modulators that may be used in the formulation include Farnesyl Acetate, Panthenyl Triacetate, Tocopheryl Acetate, or grapefruit seed extract (Citrus Grandis seed extract). In other exemplary embodiments, as discussed above, a sebum modulator may not be present. An exemplary embodiment of a formulation may also be formulated to be compatible with a separate topical acne treatment regimen, if desired.
According to an exemplary embodiment, other ingredients or additives may be added to the formulation. These may serve a variety of purposes, or may serve multiple purposes. For example, exemplary additives may be added for the purpose of protecting against pollution or protecting against ultraviolet light (UV), or for other purposes, as may be desired. Exemplary multifunction additives that may be added to the formulation include algae extract, juice pressed from blackcurrant, and raspberry leaves, butyl avocadate, zinc PCA, epilobium fleischeri extract, Laminaria Cloustoni extract, grapefruit seed extract (Citrus Grandis seed extract), or Moringa oleifera seed extract (horse-radish tree). However, in other exemplary embodiments, no multifunction additives may be added to the formulation, as may be desired.
According to an exemplary embodiment, if desired, one or more high molecular weight ingredients may be added to the formulation. For example, according to an exemplary embodiment, a large constituent such as a polymer of polyethylene glycol (PEG) may be added to the formulation. This may serve to reduce the comedogenicity of the overall formulation.
According to an exemplary embodiment, if desired, one or more of a polar sugar or a heavy metal may be added to the formulation to reduce the comedogenicity of the overall formulation. For example, according to an exemplary embodiment, zinc may be added to the formulation.
According to an exemplary embodiment, the degree of etholxylation of one or more of the molecules used in the formulation may be increased, or one or more ethoxylated materials may be added.
According to an exemplary embodiment, ingredients which are known to be comedogenic or which are potentially comedogenic, may be excluded from the formulation. For example, in an exemplary embodiment, the formulation may be oil-free, and free of laureth-4, isopropyl myristate and its analogs, lanolins, waxes, and certain conditioning agents, as well as other comedogenic or acnegenic compounds or compositions listed above or in a previous section. Occlusive agents, such as some of the above materials, can often contribute to comedogenicity and acne. In an embodiment, ingredients which are known to be irritating or potentially irritating, or ingredients that function as common allergens or which are not known to be hypoallergenic, may also be excluded from the formulation. For example, according to an exemplary embodiment, the formulation may be sulfate-free. In some embodiments, ingredients that can exacerbate the comedogenic or acnegenic properties of another ingredient but which do not themselves have significant comedogenic or acnegenic properties, such as silicone, may also be excluded. For example, in some exemplary embodiments, a silicone substitute, such as hemisqualane (a non comedogenic silicone substitute that has skin benefits) may be substituted for silicone in some quantity. In some other exemplary embodiments, silicone or another ingredient that can exacerbate the comedogenic or acnegenic effects of another ingredient may be included, and the comedogenic and acnegenic properties of the formulation may be controlled by controlling other ingredients of the formulation instead.
In an exemplary embodiment, ingredients which are known to be comedogenic or which are known to potentially be comedogenic when present in a formulation at a particular level may be kept below the level at which they are comedogenic. For example, according to an exemplary embodiment, a non-comedogenic conditioner may be provided by reducing but not eliminating the quantity of cetearyl alcohol present in a formulation; cetearyl alcohol may be comedogenic in high concentrations and minimally reactive at low concentrations.
In some embodiments, the products will also be paraben-free, formaldehyde-free, and phthalate-free, or may not have any of those components in any significant quantities.
Generally, those ingredients with a Fulton scale grade [Fulton, J. Soc. Cosmet. Chem., 40, 321-333 (November/December 1989) “Comedogenicity and irritancy of commonly used ingredients in skin care products”] of greater than about 2 may be excluded from the compositions of the invention.
In an exemplary embodiment, the pH of the formulation may be controlled at a desirable level, which may serve to reduce irritation and inflammation. It may be understood that the skin of a typical person is slightly acidic, typically having a pH of around 5.5 to 6.5, whereas many soaps, particularly bar soaps, may be formulated to have a pH that is slightly basic (around 8 to 9). This may cause skin irritation and inflammation. According to an exemplary embodiment, one or more acids may be added to the formulation such that the formulation has a pH that is neutral or slightly acidic, as desired. In some exemplary embodiments, different optimal ranges may be targeted for different non-comedogenic and/or non-acnegenic hair care formulations; for example, in an exemplary embodiment, the optimal pH of the shampoo may be 5.5-6.5 and the optimal pH of the conditioner may be 4.8-5.3. In other exemplary embodiments, pH may be controlled at another level, if desired; in other exemplary embodiments, no additives may be added to the composition in order to control pH.
In another exemplary embodiment, the composition may also be formulated to have desirable qualities as a hair care product. For example, according to an exemplary embodiment, the composition may be rinseable and designed to leave only skin-friendly residue when rinsed. This may further minimize the potential for irritation or comedogenicity from the product. The rinseability of the product may also provide other benefits, such as other benefits to the skin, such as may be desired. In another exemplary embodiment, the composition may be formulated to be color-safe or may otherwise be formulated to have minimal impact on color-treated hair.
According to an exemplary embodiment, variations of the composition may be formulated for use in specialized hair care products. In an exemplary embodiment, stratification between said hair care products may be based on hair type, benefit, or intended customer. For example, according to an exemplary embodiment, variations of an exemplary composition may be prepared specifically for and marketed at women, men, teens, and others. In an exemplary embodiment, variations of an exemplary composition may be prepared specifically for curly hair, damaged hair, dry hair, fine or flat hair, as well as more typical or normal hair. In an exemplary embodiment, variations of an exemplary composition may be prepared specifically for anti-frizzing, for promoting shine, for smoothing hair, for strengthening hair, or for any other purposes as may be desired.
An exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 1 and may be made by combining the following components in the proportions stated below. In an exemplary embodiment, the hair care product in table 1 may be used as a shampoo.
TABLE 1
Non-Comedogenic/Acnegenic Shampoo Exemplary Compositions
Ingredient Broad % Preferred
Part A Water 10.0-70.0 20.0-40.0
Disodium EDTA 0.00-1.00 0.01-0.20
Part B Glycerin 0.00-10.0 0.01-3.00
Guar Hydroxypropyltrimonium chloride 0.05-5.00 0.01-0.50
Part C Citric acid 0.00-2.00 0.01-1.00
Part D Phenoxyethanol 0.01-1.00 0.01-1.00
Ethylhexylglycerin 0.01-1.00 0.01-0.50
Polyquaternium-7 0.50-10.0 0.50-5.00
Sodium lauroyl methyl isethionate 10.0-70.0 30.0-60.0
Cocamidopropylamine oxide 1.00-20.0 5.00-10.0
Glycol distearate 0.00-10.0 0.50-1.00
Part E Water 0.00-8.00 2.00-8.00
Acrylates copolymer 1.00-15.0 2.00-6.00
Part F C13-C15 alkane 0.01-10.0 0.01-1.50
Bisabolol 0.01-1.00 0.01-0.50
Fragrance 0.00-3.00 0.01-1.00
Aminomethyl propanol 0.01-5.00 0.01-1.00
In exemplary embodiments, the components of a chemical composition provided under a trade name may be used instead of the composition provided under the trade name. For example, according to an exemplary embodiment, an exemplary formulation of hair care product may include phenoxyethanol and ethylhexylglycerin as separate components rather than including Euxyl PE 9010. This may allow the component chemicals (such as, again, phenoxyethanol and ethylhexylglycerin) to be provided in different proportions than are found in the chemical composition provided under the trade name. The acrylates copolymer listed in table 1 may be that sold under the trade name, Carbopol Aqua SF-1; however, it will be understood by those skilled in the art that any suitable lightly cross-linked rheology modifying acrylate copolymer may be employed in the practice of the invention.
According to an exemplary embodiment, an exemplary hair care product formulation of table 1 may be prepared according to the following process or a process similar to the following. In a first step, a sanitized mixing vessel may be prepared, and a quantity of deionized water may be added to the sanitized mixing vessel. The remaining components of Part A, which in the exemplary case shown in table 2 may be Disodium EDTA, may then be mixed into the mixing vessel.
In a next step, the ingredients of part B may be premixed and may then be added to the batch. The ingredients may be mixed into the batch until the batch is uniform. The ingredients of part C may then be added to the combined batch, and again mixed until the resulting batch is completely smooth.
The combined parts A, B, and C may then be heated. For example, according to an exemplary embodiment, the combined batch may be heated to a temperature within a range of 60 to 65° C.
The ingredients of Part D may then be added. The resulting batch may be mixed until all solids are melted and the batch is uniform. Once the batch has been fully mixed, the batch may be cooled to a temperature within a range of 40 to 45° C.
Once the batch has been cooled to a temperature within a range of 40 to 45° C., the parts of part E may be added. The components of part E may be pre-mixed prior to addition, which may be done, for example, concurrently with another step preceding the addition of components in part E. Once the parts of part E have been added, the resulting batch may be mixed until uniform.
Once the resulting batch has been mixed until uniform, the ingredients of part F may be added, and likewise mixed until uniform. The batch may then be cooled to a temperature of approximately 35° C. According to an exemplary embodiment, the pH of the batch may at this time be adjusted to a pH within a range of 6.50 to 6.75.
The resulting composition may be a hair care product having the appearance of semi-viscous pearlized gel. The color may be pearlescent white to off-white, which may in some exemplary embodiments be adjusted if desired. The odor may be characteristic of the fragrance added to the composition; in some exemplary embodiments, the fragrance may be reduced or left out of the composition in order to produce an odorless composition. In an exemplary embodiment, the composition may have a pH at 25° C. of between 6.5 and 7.0, a viscosity at 25° C. (RVT), at spindle 5 at 20 rpm, of between 1000 and 12,000 cPs, and a specific gravity at 25° C. of between 0.98 and 1.03. In an exemplary embodiment, the composition may be kept to a low level of viable bacterial or fungal cells or other colony-forming units (CFU), of approximately <10 CFU/g; the composition may also be kept free of pathogens.
According to an exemplary embodiment, in a production environment, one or more small-scale batches, such as lab or pilot batches, may be made prior to large-scale manufacturing. Adjustments may be made to the production process based on, for example, the results of a batch made in a particular production environment.
Another exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 2 and may be made by combining the following components in the proportions stated below. In an exemplary embodiment, the hair care product in table 2 may be used as a hair conditioner.
TABLE 2
Non-Comedogenic/Acnegenic Hair Conditioner Exemplary
Ingredient Broad % Preferred %
Part A Water 50.0-90.0 60.0-90.0
Disodium EDTA 0.00-1.00 0.01-0.10
Phenoxyethanol 0.10-5.00 0.75-1.25
Ethylhexylglycerin 0.10-2.00 0.10-0.50
Citric acid 0.01-1.00 0.01-0.50
Stearamidopropyl dimethylamine 1.00-10.0 1.00-2.50
Polysorbate 80 0.00-5.00 0.10-1.00
Part B Cetearyl alcohol 0.50-10.0 1.00-5.00
Behentrimonium chloride 0.10-5.00 0.50-3.00
Cetyl palmitate 0.50-5.00 1.00-4.00
C13-C15 alkane 0.50-15.0 2.00-7.00
Shea butter cetyl esters 0.10-8.00 0.50-2.00
Part C Glycerin 0.00-10.0 0.10-2.00
Bisabolol 0.01-1.00 0.01-0.50
Fragrance 0.00-5.00 0.50-2.00
According to an exemplary embodiment, an exemplary hair care product formulation of table 2 may be prepared according to the following process or a process similar to the following. In a first step, a sanitized mixing vessel may be prepared, and a quantity of deionized water may be added to the sanitized mixing vessel. This DI water may then be heated to a temperature within the ranges of 80 to 85° C.
The remaining components of Part A may then be mixed into the mixing vessel. According to an exemplary embodiment, the remaining components of Part A may be added in an order or sequence, which may for example be the order in which they are shown in the table. In an exemplary embodiment, the ingredients may be added only once the previous ingredient has been fully dissolved. For example, in an exemplary embodiment, the phenoxyethanol of part A may be added, mixed until fully dissolved, and only then will the ethylhexylglycerin of part B be added.
The components of part B may be combined in a separate mixing vessel. According to an exemplary embodiment, the components of part B may be heated to a temperature in the range of 80 to 85° C. after combination, and may then be mixed until uniform.
The components of part B may then be combined with the components of part A, for example by adding the components of part B to the mixing vessel of part A. The resulting batch may then be mixed until it is smooth and uniform. The batch may then be cooled to a temperature within the range of 35 to 40° C.; according to an exemplary embodiment, mixing may be continued during this cooling process.
The ingredients of part C may then be added to the combined batch of parts A and B. According to an exemplary embodiment, ingredients may be added alone or in combination, as may be desired. The resulting batch may be mixed until uniform; following this, it may continue to be mixed and may be cooled (for example by ambient temperature) until the temperature of the batch reaches a temperature between 30 and 35° C.
The resulting composition may be a hair care product having the appearance of viscous cream. The color may be white to off-white, which may in some exemplary embodiments be adjusted if desired. The odor may be characteristic of the fragrance added to the composition; in some exemplary embodiments, the fragrance may be reduced or left out of the composition in order to produce an odorless composition. In an exemplary embodiment, the composition may have a pH at 25° C. of between 3.8 and 5.5 a viscosity at 25° C. (RVT), at spindle 5 at 20 rpm, of between 2000 and 30,000 cPs, and a specific gravity at 25° C. of between 0.98 and 1.03. In an exemplary embodiment, the composition may be kept to a low level of viable bacterial or fungal cells or other colony-forming units (CFU), of approximately <10 CFU/g; the composition may also be kept free of pathogens.
Another exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 3 and may be made by combining the following components in the proportions stated below. In an exemplary embodiment, the hair care product in table 3 may be used as a curly styling cream.
TABLE 3
Non-Comedogenic/Acnegenic Curly Styling
Cream Exemplary Compositions
Ingredient Broad % Preferred %
Part A Water 50.0-90.0 75.0-85.0
Disodium EDTA 0.00-1.00 0.05-0.20
Phenoxyethanol 0.10-5.00 0.75-1.25
Ethylhexylglycerin 0.10-2.00 0.10-0.50
Citric acid 0.01-1.00 0.01-0.50
Stearamidopropyl dimethylamine 1.00-10.0 1.00-2.50
Polysorbate 80 0.00-5.00 0.10-1.00
Part B Cetearyl alcohol 0.50-10.0 1.00-5.00
Behentrimonium chloride 0.10-5.00 0.50-3.00
Squalene 0.00-8.00 0.50-5.00
C13-C15 alkane 0.50-15.0 1.00-5.00
Shea butter cetyl esters 0.10-8.00 0.50-5.00
Part C Polyimide-1 0.00-3.00 0.10-1.00
Part D Puricare ™ LS9727* 0.00-8.00 1.00-3.00
Bisabolol 0.01-1.00 0.01-1.00
Hydrolyzed Pea Protein 0.00-8.00 0.50-2.00
Keratrix ™** 0.00-10.0 1.50-4.50
Fragrance 0.00-5.00 0.01-2.00
*Includes water, glycerin, moringa Oleifera seed extract
**Includes water, glycerin, hydrolyzed ceratonia siliqua seed extract, zea mays starch, guar hydroxypropyltrimonium chloride, polyquaternium-7
According to an exemplary embodiment, an exemplary hair care product formulation of table 3 may be prepared according to the following process or a process similar to the following. In a sanitized mixing vessel, add disodium EDTA and water from Part A. Begin heating to 75-80° C. while mixing. Add remaining ingredients of Part A. Mix with heat until clear and all solids are dissolved. In a separate vessel, combine ingredients in Part B. Heat Part B to 75-80° C. and mix until uniform. Add Part B to Part A and mix until smooth and uniform. Add Part C to batch, mix until uniform and cool to 35-40° C. Add ingredients in Part D and mix until uniform. Continue mixing batch until temperate reaches 30-35° C. The product has the appearance of a white viscous cream with a pH@ 25° C.: 3.8-4.2; viscosity @ 25° C. (RVT): Spindle 5, 20 RPM 4,000-8,000 cPs; specific gravity @ 25° C.: 0.98-1.03; microbiology <10 CFU/g, No pathogens
Another exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 4 and may be made by combining the following components in the proportions stated below. In an exemplary embodiment, the hair care product in table 4 may be used as a blow dry styling cream.
TABLE 4
Non-Comedogenic/Acnegenic Blow Dry Styling
Cream Exemplary Compositions
Ingredient Broad % Preferred %
Part A Water 50.0-90.0 75.0-85.0
Disodium EDTA 0.00-1.00 0.05-0.20
Phenoxyethanol 0.10-5.00 0.75-1.25
Ethylhexylglycerin 0.10-2.00 0.10-0.50
Citric acid 0.01-1.00 0.01-0.50
Stearamidopropyl dimethylamine 1.00-10.0 1.00-2.50
Polysorbate 80 0.00-5.00 0.10-1.00
Part B Cetearyl alcohol 1.00-5.00 1.00-5.00
Behentrimonium chloride 0.50-3.00 0.50-3.00
Squalene 0.50-5.00 0.50-5.00
C13-C15 alkane 1.00-5.00 1.00-5.00
Shea butter cetyl esters 0.50-5.00 0.50-5.00
Part C Puricare ™ LS9727 0.00-8.00 1.00-3.00
Bisabolol 0.01-1.00 0.01-1.00
Hydrolyzed Pea Protein 0.00-8.00 0.50-2.00
Keratrix ™ 0.00-10.0 1.50-4.50
Fragrance 0.00-5.00 0.01-2.00
According to an exemplary embodiment, an exemplary hair care product formulation of table 4 may be prepared according to the following process or a process similar to the following.
In a sanitized mixing vessel, add disodium EDTA and water from Part A. Begin heating to 75-80° C. while mixing. Add remaining ingredients of Part A. Mix with heat until clear and all solids are dissolved. In a separate vessel, combine ingredients in Part B. Heat Part B to 75-80° C. and mix until uniform. Add Part B to Part A and mix until smooth and uniform. Continue mixing and cool to 35-40° C. Add ingredients in Part C and mix until uniform. Continue mixing batch until temperate reaches 30-35° C. The product has the appearance of a white viscous cream with a pH@ 25° C.: 3.8-4.2; viscosity @ 25° C. (RVT): Spindle 5, 20 RPM 3,000-8,000 cPs; specific gravity @ 25° C.: 0.98-1.03; microbiology <10 CFU/g, No pathogens
According to an exemplary embodiment, in a production environment, one or more small-scale batches, such as lab or pilot batches, may be made prior to large-scale manufacturing. Adjustments may be made to the production process based on, for example, the results of a batch made in a particular production environment.
Alternative compositions may also be envisioned, for example for other compositions of shampoos or conditioners or for other types of hair care products, such as styling gels or even combined shampoos and conditioners. For example, some embodiments may have relative compositions different from those shown; an exemplary composition may have a higher weight percent of one component chemical and a lower weight percent of a second component chemical. Equivalent or substantially equivalent component chemicals may also be substituted for chemicals within a composition. Appropriate substitutions may be appreciated by one of skill in the art.
The foregoing description and accompanying drawings illustrate the principles, preferred embodiments and modes of operation of the invention. However, the invention should not be construed as being limited to the particular embodiments discussed above. Additional variations of the embodiments discussed above will be appreciated by those skilled in the art.
Therefore, the above-described embodiments should be regarded as illustrative rather than restrictive. Accordingly, it should be appreciated that variations to those embodiments can be made by those skilled in the art without departing from the scope of the invention as defined by the following claims.

Claims (17)

What is claimed is:
1. A hair and scalp care formulation that does not have a tendency to block pores or cause acne, wherein the formulation comprises:
water, wherein the water is present in an amount between 50 and 90%;
C13-C15 alkanes, wherein the C13-C15 alkanes are present in an amount up to 15%;
bisabolol, wherein the bisabolol is present in an amount between 0.01% and 1%;
citric acid, wherein the citric acid is present in an amount up to 2%;
disodium EDTA, wherein the disodium EDTA is present in an amount up to 1%; and
an antimicrobial;
wherein the formulation further comprises hydrolyzed ceratonia siliqua seed extract, Zea mays starch, and guar hydroxypropyltrimonium chloride, wherein the formulation excludes parabens and sulfates, and wherein the formulation is fragrance free.
2. The formulation of claim 1, wherein the formulation further comprises ethylhexylglycerin in an amount up to 2%.
3. The formulation of claim 1, further comprising cetearyl alcohol, wherein the cetearyl alcohol is present in an amount between 0.5% to 10.0% and behentrimonium chloride, wherein the behentrimonium chloride is present in an amount between 0.1% to 5.0%.
4. The formulation of claim 1, wherein the formulation further comprises glycerin and Moringa Oleifera Seed Extract.
5. The formulation of claim 1, further comprising shea butter cetyl esters.
6. The formulation of claim 5, wherein the shea butter cetyl esters are present in an amount between 0.1 and 8.0%.
7. A hair and scalp care formulation that does not have a tendency to block pores or cause acne, wherein the formulation comprises:
water, wherein the water is present in an amount between 50 and 90%;
C13-C15 alkanes, wherein the C13-C15 alkanes are present in an amount up to 15%;
bisabolol, wherein the bisabolol is present in an amount between 0.01% and 1%;
citric acid, wherein the citric acid is present in an amount up to 2%;
disodium EDTA, wherein the disodium EDTA is present in an amount up to 1%, a combination of a hydrolyzed ceratonia siliqua seed extract, Zea mays starch, guar hydroxypropyltrimonium chloride, and polyquaternium-7, wherein the combination of said hydrolyzed ceratonia siliqua seed extract, said Zea mays starch, said guar hydroxypropyltrimonium chloride, and said polyquaternium-7 is present in an amount up to 10%,
wherein the formulation excludes parabens and sulfates, and wherein the formulation is fragrance free.
8. A hair and scalp care formulation that does not have a tendency to block pores or cause acne, wherein the formulation comprises:
water, wherein the water is present in an amount between 50 and 90%;
C13-C15 alkanes, wherein the C13-C15 alkanes are present in an amount up to 15%;
bisabolol, wherein the bisabolol is present in an amount between 0.01% and 1%;
citric acid, wherein the citric acid is present in an amount up to 2%;
disodium EDTA, wherein the disodium EDTA is present in an amount up to 1%; and
wherein the formulation further comprises glycerin, Moringa Oleifera seed extract, hydrolyzed ceratonia siliqua seed extract, Zea mays starch, guar hydroxypropyltrimonium chloride, and polyquaternium-7.
9. A hair and scalp care formulation that does not have a tendency to block pores or cause acne, wherein the formulation comprises:
water, wherein the water is present in an amount between 50 and 90%;
C13-C15 alkanes, wherein the C13-C15 alkanes are present in an amount up to 15%;
bisabolol, wherein the bisabolol is present in an amount between 0.01% and 1%;
citric acid, wherein the citric acid is present in an amount up to 2%;
disodium EDTA, wherein the disodium EDTA is present in an amount up to 1%; and
wherein the formulation further comprises a combination of glycerin and Moringa Oleifera seed extract, wherein the combination of said glycerin and said Moringa Oleifera seed extract is present in an amount up to 8%, and
wherein the formulation further comprises a combination of a hydrolyzed ceratonia siliqua seed extract, Zea mays starch, guar hydroxypropyltrimonium chloride, and polyquaternium-7, wherein the combination of said hydrolyzed ceratonia siliqua seed extract, said Zea mays starch, said guar hydroxypropyltrimonium chloride, and said polyquaternium-7 is present in an amount up to 10%.
10. The formulation of claim 9, wherein the formulation further comprises shea butter cetyl esters.
11. The formulation of claim 10, wherein the shea butter cetyl esters are present in an amount between 0.1 and 8.0%.
12. The formulation of claim 9, wherein the formulation further comprises ethylhexylglycerin, cetearyl alcohol, behentrimonium chloride, and shea butter cetyl esters.
13. A hair and scalp care formulation that does not have a tendency to block pores or cause acne, wherein the formulation comprises:
water, wherein the water is present in an amount between 50 and 90%;
C13-C15 alkanes, wherein the C13-C15 alkanes are present in an amount up to 15%;
glycerin, wherein the glycerin is present in an amount in an amount up to 10%; and
an antimicrobial,
wherein the formulation further comprises Moringa Oleifera seed extract, hydrolyzed ceratonia siliqua seed extract, Zea mays starch, guar hydroxypropyltrimonium chloride, and polyquaternium-7;
wherein the formulation excludes parabens and sulfates, and
wherein the formulation is fragrance free.
14. The formulation of claim 13, further comprising behentrimonium chloride and cetearyl alcohol, wherein the behentrimonium chloride is present in an amount between 0.1% to 5.0%, and wherein the cetearyl alcohol is present in an amount between 0.5 to 10%.
15. The formulation of claim 13, wherein the formulation further comprises shea butter cetyl esters.
16. The formulation of claim 13, wherein the formulation further comprises shea butter cetyl esters, wherein the shea butter cetyl esters are present in an amount between 0.1 and 8.0%.
17. The formulation of claim 13, wherein the formulation further comprises ethylhexylglycerin, cetearyl alcohol, behentrimonium chloride, and shea butter cetyl esters.
US16/192,676 2016-06-10 2018-11-15 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use Active US11160746B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US16/192,676 US11160746B2 (en) 2016-06-10 2018-11-15 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US16/739,774 US10813872B2 (en) 2016-06-10 2020-01-10 Hair and scalp formulations
US17/496,680 US20220079865A1 (en) 2016-06-10 2021-10-07 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662348510P 2016-06-10 2016-06-10
US15/618,420 US9949915B2 (en) 2016-06-10 2017-06-09 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US15/957,238 US10159637B2 (en) 2016-06-10 2018-04-19 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US16/192,676 US11160746B2 (en) 2016-06-10 2018-11-15 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/957,238 Continuation US10159637B2 (en) 2016-06-10 2018-04-19 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US16/739,774 Continuation US10813872B2 (en) 2016-06-10 2020-01-10 Hair and scalp formulations
US17/496,680 Continuation US20220079865A1 (en) 2016-06-10 2021-10-07 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Publications (2)

Publication Number Publication Date
US20190183775A1 US20190183775A1 (en) 2019-06-20
US11160746B2 true US11160746B2 (en) 2021-11-02

Family

ID=60572142

Family Applications (5)

Application Number Title Priority Date Filing Date
US15/618,420 Active US9949915B2 (en) 2016-06-10 2017-06-09 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US15/957,238 Active US10159637B2 (en) 2016-06-10 2018-04-19 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US16/192,676 Active US11160746B2 (en) 2016-06-10 2018-11-15 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US16/739,774 Active US10813872B2 (en) 2016-06-10 2020-01-10 Hair and scalp formulations
US17/496,680 Pending US20220079865A1 (en) 2016-06-10 2021-10-07 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US15/618,420 Active US9949915B2 (en) 2016-06-10 2017-06-09 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US15/957,238 Active US10159637B2 (en) 2016-06-10 2018-04-19 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Family Applications After (2)

Application Number Title Priority Date Filing Date
US16/739,774 Active US10813872B2 (en) 2016-06-10 2020-01-10 Hair and scalp formulations
US17/496,680 Pending US20220079865A1 (en) 2016-06-10 2021-10-07 Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Country Status (5)

Country Link
US (5) US9949915B2 (en)
EP (1) EP3468530A4 (en)
JP (1) JP6992057B2 (en)
CA (1) CA3026108A1 (en)
WO (1) WO2017214497A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017214497A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use
US20200352164A1 (en) * 2018-01-17 2020-11-12 Sharon Laboratories Ltd. Antimicrobial preservative compositions
FR3125416A1 (en) * 2021-07-22 2023-01-27 L'oreal Cosmetic composition comprising at least one fatty amine, at least 6% by weight of at least one solid fatty substance and at least one liquid fatty substance
WO2024030568A1 (en) * 2022-08-04 2024-02-08 Clarity Cosmetics Inc. Skin and hair care formulations

Citations (352)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661475A (en) * 1983-09-30 1987-04-28 Diamalt Aktiengesellschaft Gelling agents and thickeners based on Cassia-galactomannans
US5306489A (en) * 1992-07-24 1994-04-26 Revlon Consumer Products Corporation Hair care products containing N-alkoxyalkylamides
US5759527A (en) 1996-10-02 1998-06-02 Colgate-Palmolive Company Hair conditioning composition
US5863546A (en) 1997-03-02 1999-01-26 Swinehart; James M Cosmetic composition
US6113891A (en) 1997-11-19 2000-09-05 Hercules Incorporated Fluidized polymer suspensions of cationic polysaccharides in emollients and use thereof in preparing personal care compositions
US6165493A (en) 1997-10-22 2000-12-26 New York Blood Center, Inc. "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US6193986B1 (en) 1997-02-25 2001-02-27 The Nisshin Oil Mills, Ltd. Oily composition with increased stability and process for producing the same
US6268355B1 (en) 1997-06-25 2001-07-31 Teikoku Seiyaku Co., Ltd. Stable aspirin-containing preparations for external use
US6281236B1 (en) 1999-07-23 2001-08-28 Alwyn Company, Inc. Oil-in-water emulsion with improved stability
US6312675B1 (en) 2000-09-14 2001-11-06 Jeffrey Alan Deane Hair cleaner
US20010053801A1 (en) 2000-05-05 2001-12-20 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Inverse latexes based on white mineral oil, squalene or hydrogenated polyisobutene, cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions containing them
US6350432B1 (en) 1999-03-19 2002-02-26 Generex Pharmaceuticals Incorporated Pressurized container having an aerosolized pharmaceutical composition
US6375975B1 (en) 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US20020048603A1 (en) 2001-12-07 2002-04-25 Fred Burmeister Hydrogel composition
US6406708B1 (en) 1998-05-12 2002-06-18 Interhealth Ab Therapeutic compositions
US6436367B1 (en) 1998-12-21 2002-08-20 Generex Pharmaceuticals Inc. Aerosol formulations for buccal and pulmonary application
US6444213B1 (en) 1997-08-28 2002-09-03 Daikin Industries Ltd. Cosmetics with hydrofluoroether (HFE)
EP1097695B1 (en) 1999-11-08 2002-09-18 L'oreal Composition containing an aqueous suspension of particles of an organopolysiloxane elastomer and cosmetical uses thereof
US20020143063A1 (en) 2001-01-29 2002-10-03 Alvarado Robert M. Hair conditioner composition that is non-irritating to the eyes
US20020155083A1 (en) 2001-04-19 2002-10-24 Morris Mann Dermal regeneration methods and compositions related thereto in conjunction with laser phototherapy, microdermabrasion and epidermabrasion
US6471954B2 (en) 2001-01-24 2002-10-29 Cortex Technology Aps Method for the production and use of a cream containing vitamin-A
US20020176876A1 (en) 2001-01-23 2002-11-28 Harris Dennis H. Topical therapeutic skin care system
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US20030003069A1 (en) 2001-04-04 2003-01-02 Carson John C. Multiple phase foaming personal cleansing products
US20030039619A1 (en) 2000-01-28 2003-02-27 Joachim Bunger Galenic formulation
US20030093045A1 (en) 2001-11-13 2003-05-15 Erdman Carol L. Absorbing article having zoned areas of hydrophilicity
US20030102004A1 (en) 2000-01-19 2003-06-05 Yoshihiro Hirata Hair styling method
US20030113315A1 (en) 2000-02-24 2003-06-19 Yoshihiro Hirata Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
EP1140019B1 (en) 1998-12-21 2003-06-25 Generex Pharmaceuticals Inc. Aerosol formulations for buccal and pulmonary application
US20030165585A1 (en) 2002-02-25 2003-09-04 Mann Maria A. Xanthine-containing compositions for oral administration and uses related thereto
US20030185920A1 (en) 2000-08-03 2003-10-02 Siro Passi Sebum-like preparation to be used as lipidic component in cosmetics
US6649151B2 (en) 2001-02-06 2003-11-18 Coty Inc. Cosmetic formulation
US6673861B2 (en) 2000-05-05 2004-01-06 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Inverse latices self-invertible with respect to white mineral oils, squalane, hydrogenated polyisobutene, isohexadecane or isododecane and cosmetic, democosmetic, dermopharmaceutical or pharmaceutical compositions comprising them
US20040013618A1 (en) 2000-09-28 2004-01-22 Siro Passi Cosmetic formulation
US6699464B1 (en) 2001-07-30 2004-03-02 Stiefel Laboratories, Inc. Compositions for treatment of hyperpigmentation and methods for making and using such compositions
US20040057917A1 (en) 2002-09-24 2004-03-25 Hans-Dieter Prentner Pharmaceutical composition for treatment and /or prevention of a light-dermatosis
US20040072915A1 (en) 2000-04-27 2004-04-15 Andre Rougereau Novel medicines based on sesquiterpene mixtures
US6723309B1 (en) 2002-06-10 2004-04-20 Jeffrey Alan Deane Hair cleansing conditioner
US6723689B1 (en) 2003-01-08 2004-04-20 Becton Dickinson And Company Emollient alcohol skin disinfecting formulation
EP1061799B1 (en) 1998-03-12 2004-04-28 THE PROCTER &amp; GAMBLE COMPANY Tissue paper having antimicrobial skin lotion
EP0947491B1 (en) 1998-04-01 2004-05-12 Nippon Petrochemicals Company, Limited Method for producing highly pure squalane
US20040186042A1 (en) 2001-07-09 2004-09-23 Gerhard Schmaus Iso-$g(b)-bisabolol as fragrance and aroma substance
US20040185016A1 (en) 2002-07-30 2004-09-23 Popp Karl F Compositions for treatment of hyperpigmentation and methods for making and using such compositions
US20040258651A1 (en) 2003-06-18 2004-12-23 Goldschmidt Ag Use of alkylguanidine compounds for the treatment and after-treatment of hair
US20040258652A1 (en) 2003-06-18 2004-12-23 Goldschmidt Ag Hair treatment compositions and hair after-treatment compositions for protection against damage by chemical treatment and for the repair of already damaged hair comprising as active substances alkylguanidine compounds
US20050008604A1 (en) 2003-06-17 2005-01-13 Schultz Thomas M. Modified soy proteins in personal care compositions
US20050025847A1 (en) 2003-02-26 2005-02-03 Program For Appropriate Technology In Health Microbicidal compositions and method of use
US20050025817A1 (en) 2003-07-03 2005-02-03 Bhatia Kuljit S. Delivery system for topical medications
EP1000603B1 (en) 1998-10-01 2005-02-09 Beiersdorf Aktiengesellschaft Use of surface-active citric acid esters for stabilizing flavones, flavanones or flavonoids, and synergistic mixtures, cosmetic and dermatological preparations containing them
US20050031571A1 (en) 2003-05-16 2005-02-10 Khaiat Alain V. Topical treatment of ingrown hairs
WO2005018629A1 (en) 2003-08-12 2005-03-03 Yarbrough William M Treatment for acne vulgaris and method of use
US20050074474A1 (en) 2003-10-03 2005-04-07 The Procter & Gamble Company Topical composition
US20050089488A1 (en) 2003-10-27 2005-04-28 Kim Joo W. Deodorant composition with monocyclic, unsaturated sequiterpene alcohols and glyceryl monoalkyl ethers as synergistic active deodorant agents
US6896897B2 (en) 1999-07-23 2005-05-24 Alwyn Company, Inc. Flexible applicator for applying oil-in-water emulsion with improved stability
US20050152993A1 (en) 2002-01-25 2005-07-14 Mariana De Oliveira Composition for and method of treatment for skin ailments
US20050158262A1 (en) 2003-12-19 2005-07-21 Eric Parris Cosmetic composition comprising a cationic agent, a polymer comprising a hetero atom and an oil, and cosmetic treatment process
US6923954B2 (en) 2001-08-06 2005-08-02 Kao Corporation Conditioner
US20050169865A1 (en) 2003-12-19 2005-08-04 Eric Parris Cosmetic composition comprising at least one cationic agent, at least one semi-crystalline polymer and at least one oil, and cosmetic treatment process
US20050175646A1 (en) 2001-10-30 2005-08-11 Philippe Catroux Cosmetic composition that mimics sebum and the use thereof
EP1222915B1 (en) 2001-01-16 2005-09-07 Uni-Charm Corporation Wet wiper impregnated with plant extracts
US20050220810A1 (en) 2002-06-25 2005-10-06 Shiseido Company, Ltd. Anti-aging preparation
US20050226838A1 (en) 2004-04-08 2005-10-13 Thomas Krause Hair treatment compositions containing N-hydroxy-alkyl-O-benzyl chitosans and methods of using same
US20050249761A1 (en) 2004-02-18 2005-11-10 Joachim Buenger Topical composition comprising at least one aryl oxime and bisabolol
US20050276767A1 (en) 2002-10-18 2005-12-15 L'oreal Composition containing an oily phase and a naphthopyran dye, cosmetic treatment processes
EP0978270B1 (en) 1997-10-31 2006-02-01 Shiseido Company Limited Emulsified cosmetic face pack
US20060024258A1 (en) 2004-08-02 2006-02-02 L'oreal Water-in-oil emulsion comprising a non-volatile non-silicone oil, cationic and nonionic surfactants, and an alkylmonoglycoside or alkylpolyglycoside
US20060024256A1 (en) * 2002-06-04 2006-02-02 Wells Robert L Shampoo containing a gel network
US20060029627A1 (en) 2000-07-26 2006-02-09 Yuuzou Tsuchida Antipruritic composition and wound-healing-promoting composition
US20060051311A1 (en) 2004-09-04 2006-03-09 Andrea Walter Hair treatment composition containing a combination of at least three different polymers
US20060051310A1 (en) 2004-08-02 2006-03-09 L'oreal Water-in-oil emulsion comprising a non-volatile non-silicone oil, a cationic surfactant, a polyolefin with polar portion(s), and an alkylmonoglycoside or alkylpolyglycoside
US20060057075A1 (en) 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20060062749A1 (en) 2004-09-16 2006-03-23 Shelton Michael C personal care products incorporating cellulosic fatty acid esters
US7078050B2 (en) 1999-06-01 2006-07-18 Normajean Fusco Composition for topical treatment
EP1192934B1 (en) 2000-09-30 2006-10-18 Beiersdorf Aktiengesellschaft Emulsion preparations of the w/o type with an increased water content based on lipidic components
EP1410784B1 (en) 2002-10-18 2007-02-07 L'oreal Cosmetic composition comprising an oil phase and a naphthopyran dye and method
US7182939B2 (en) 1998-10-26 2007-02-27 Shiseido Company, Ltd. Hair tonic composition
US20070082042A1 (en) 2004-08-06 2007-04-12 Deok-Hoon Park Multiple-layered liposome and preparation method thereof
US20070082017A1 (en) 2004-01-10 2007-04-12 Tseng Scheffer C Lipid compositions and methods of use
US20070154439A1 (en) 2006-01-04 2007-07-05 Paula Dorf Cosmetic composition for use around the eyes
US20070166241A1 (en) 2000-04-21 2007-07-19 Baker Amy E Salicylic acid acne spray formulations and methods for treating acne with same
US7247173B2 (en) 2003-12-17 2007-07-24 Henkel Kommandit Gesellschaft Auf Aktien Tinting agent in tubes
US7262180B2 (en) 2002-04-09 2007-08-28 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
US20070243147A1 (en) 2004-07-24 2007-10-18 Beiersdorf Ag Skin and/or Hair Composition Containing Compounds for Increasing The Tanning of Skin
US7294153B2 (en) 2003-12-17 2007-11-13 Henkel Kommanditgesellschaft Auf Aktien Caring oxidation coloring agent in a tube
US20070264363A1 (en) 2003-11-13 2007-11-15 Compton Deveolopment Ltd Molluscicidal and Anti-Barnacle Compounds
US20070265353A1 (en) 2004-08-27 2007-11-15 Senju Pharmaceutical Co., Ltd. Eye Drops for the Treatment of Dry Eye
US7297717B2 (en) 2000-04-27 2007-11-20 Kao Corporation Emulsion cosmetic
US20070286838A1 (en) 2006-06-09 2007-12-13 T.F.H. Publications, Inc. Tamanu Oil Products
US20070297992A1 (en) 2005-06-20 2007-12-27 Hartmut Schiemann Product release system to atomize compositions containing hair-conditioning ingredients
US7314634B2 (en) 2002-02-22 2008-01-01 Steven Hernandez Use of polyphenols to treat skin conditions
US20080020004A1 (en) 2004-02-18 2008-01-24 Susanne Birkel Hair-Treatment Agent Comprising Terpolymer Of Vinylpyrrolidone, Methacrylamide And Vinylimidazole And Active Ingredients And Additives
US20080032384A1 (en) 2004-04-22 2008-02-07 Takehiko Nomura Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton
US20080057008A1 (en) 2004-03-18 2008-03-06 Imperial Chemical Industries Plc Metal Oxide Dispersion
US20080069898A1 (en) * 2004-11-11 2008-03-20 Smith Christopher F Topical Compositions Comprising Myrica Gale Oil
US20080112898A1 (en) 2005-06-20 2008-05-15 Hartmut Schiemann Product release system to atomize polymer-containing cosmetic hair compositions
US7393630B2 (en) 1997-12-16 2008-07-01 Novartis Vaccines And Diagnostics, Inc. Use of microparticles combined with submicron oil-in-water emulsions
US20080171030A1 (en) 2005-11-01 2008-07-17 Juice Beauty Compositions for juice-based moisturizers
US20080175931A1 (en) 2007-01-19 2008-07-24 Nathalie Schlemer Cosmetic foundation
US20080175805A1 (en) 2007-01-19 2008-07-24 Guthy-Renker Corporation Cosmetic foundation
US20080206371A1 (en) 2007-02-22 2008-08-28 Healing Skin Llc Novel burn treatment composition
US7427407B2 (en) 2001-02-28 2008-09-23 Kao Corporation Cosmetics
EP1629865B1 (en) 2004-08-02 2008-10-08 L'oreal Water-in-oil emulsion comprising a non-volatile non-siliconized oil, a cationic surfactant, a polyolfin with polar areas, and an alkylmonoglycosid or an alkylpolyglycoside
US20080275118A1 (en) 2008-06-12 2008-11-06 Shaw Mari M Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
US7459166B2 (en) 2003-05-28 2008-12-02 Coty B.V. Cosmetic product containing mineral water for remineralizing and rejuvenating the skin
US20080305057A1 (en) 2007-06-07 2008-12-11 Damage Control Technologies, Inc. New and improved skin treatment systems
EP1631245B1 (en) * 2003-05-29 2009-01-28 Colgate-Palmolive Company Transparent conditioning shampoo
EP1816998B1 (en) 2004-11-22 2009-03-18 Symrise GmbH & Co. KG Formulations comprising ceramides and/or pseudoceramides and (alpha-)bisabolol for combating skin damage
US20090074888A1 (en) 2004-07-02 2009-03-19 Bhatia Kuljit S Stable cleanser compositions containing sulfur
US20090074700A1 (en) 2007-09-14 2009-03-19 L'oreal Compositions and methods for imparting shine onto hair
US20090098079A1 (en) 2005-06-20 2009-04-16 The Procter & Gamble Company Product release system for atomizing cosmetic hair compositions containing cationic polymers
US20090123398A1 (en) 2007-11-13 2009-05-14 Presperse, Inc. Silicon-free hydrocarbons providing aesthetic volatility
US20090130220A1 (en) 2007-11-20 2009-05-21 Johnson Pamela A Cosmetic composition having pomace olive oil
US20090170816A1 (en) 2005-11-18 2009-07-02 Farmaleis S.L. Combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer
CN101485622A (en) * 2009-03-03 2009-07-22 张嘉恒 Shampoo containing extract of Moringa oleifera and preparation method thereof
US20090191136A1 (en) 2008-01-28 2009-07-30 Beiersdorf Ag Use of active substance complexes of panthenol, glycerol, citrate and/or bisabolol against pollen allergies
EP2090295A1 (en) 2008-02-11 2009-08-19 Wella Aktiengesellschaft Method and composition for reducing the drying time of hair
US20090220625A1 (en) 2005-10-14 2009-09-03 Martina Herrmann Synergistic mixtures of bisabolol and ginger extract
EP2029170B1 (en) 2006-11-08 2009-10-28 Novartis AG Quality control methods for oil-in-water emulsions containing squalene
US20100008880A1 (en) 2006-05-03 2010-01-14 John Castro Clear Cosmetic Compositions And Methods Of Using
WO2010023559A2 (en) 2008-08-29 2010-03-04 L'oreal Methods and kits for permanently coloring hair using a developer composition containing an oxidizer composition and a shampoo
US20100074853A1 (en) 2006-01-19 2010-03-25 Mary Kay Inc. Compositions Comprising Kakadu Plum Extract Or Acai Berry Extract
US7691792B1 (en) 2009-09-21 2010-04-06 Amyris Biotechnologies, Inc. Lubricant compositions
US20100143512A1 (en) 2008-12-01 2010-06-10 Basf Beauty Care Solutions France S.A.S. Novel sebum secretion inhibitory agent
US7744856B2 (en) 2005-10-03 2010-06-29 Biotech Research And Development Corporation Formulations with feruloyl glycerides and methods of preparation
US7759332B2 (en) 2006-08-04 2010-07-20 Glory F & D Co., Ltd. Cytotropic heterogeneous molecular lipids (CHML), method of preparation, and methods of treating patients with multiple cancers
US7763180B2 (en) 2004-09-07 2010-07-27 Kao Corporation Wrinkle-removing composition
EP2218447A1 (en) 2008-11-04 2010-08-18 PharmaSol GmbH Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
US7807188B2 (en) 2002-05-03 2010-10-05 Children's Hospital Medical Center Simulated vernix compositions for skin cleansing and other applications
EP1576882B1 (en) 2004-03-18 2010-10-06 The State Of Israel-Ministry Of Agriculture & Rural Development Pest-impervoius packaging material and pest-control composition
US7825207B2 (en) 2005-02-02 2010-11-02 Goldschmidt Gmbh Siloxanes containing guanidino groups and use thereof for cosmetic formulations
US7829067B2 (en) 2004-03-03 2010-11-09 Bio-Botanica, Inc. Method and composition for treating oral bacteria and inflammation
US7832413B2 (en) 2006-10-27 2010-11-16 Goody Products, Inc. Therapeutic styling brush with infusion delivery
US7845360B2 (en) 2006-10-27 2010-12-07 Goody Products, Inc. Therapeutic styling brush with infusion delivery
EP1116483B1 (en) 1999-07-27 2010-12-08 Shiseido Company Limited Oil-in-water emulsion composition
US7858840B2 (en) 2000-01-25 2010-12-28 Uni-Charm Corporation Absorbent article containing skin-protective ingredient
WO2010151240A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
EP1778289B1 (en) 2004-08-03 2011-01-12 Vital Health Sciences Pty Ltd. Carrier for enteral administration
US7883729B2 (en) 2000-03-20 2011-02-08 Laboratories Expanscience Natural vegetable oil concentrated in unsaponifiable matters as food ingredient
US7901465B2 (en) 2006-09-01 2011-03-08 Kao Corporation One-part hair dye composition
US7906557B2 (en) 2002-06-19 2011-03-15 Maruha Nichiro Seafoods, Inc. Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether
WO2011056226A1 (en) 2009-11-05 2011-05-12 Mercia Pharma Llc Adjuvanted nanoparticulate influenza vaccine
US20110112041A1 (en) 2009-10-01 2011-05-12 Baylor Research Institute Treatment of Male-Pattern Baldness by Local Induction of the Metabolic Defect of Fabry Disease
US7956025B2 (en) 2002-04-30 2011-06-07 Cognis Ip Management Gmbh Finished fibers and textiles
US7959935B2 (en) 2002-05-03 2011-06-14 Children's Hospital Medical Center Simulated vernix compositions for skin cleansing and other applications
EP1014916B2 (en) 1997-08-18 2011-06-15 Neubourg Skin Care GmbH & Co. KG Foaming skin cream, uses thereof and a method for producing the same
US20110150810A1 (en) * 2008-09-05 2011-06-23 Kpss-Kao Professional Salon Services Gmbh Conditioning composition for hair
US8021674B2 (en) 2002-06-14 2011-09-20 Coty B.V. Cosmetic gel product on the basis of oils and gelling agents
US20110256249A1 (en) 2010-04-16 2011-10-20 Doreen Campbell Hair and scalp care formulations for treating and preventing acne and related skin conditions
WO2011146837A1 (en) 2010-05-21 2011-11-24 Amyris, Inc. Squalane and isosqualane compositions and methods for preparing the same
JP2011246361A (en) 2010-05-24 2011-12-08 Kao Corp Hair cosmetic
US20110305737A1 (en) 2010-06-09 2011-12-15 NY Derm LLC Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology
US8092813B1 (en) 2007-12-28 2012-01-10 Novartis Ag Polychlorinated biphenyls and squalene-containing adjuvants
WO2012011904A1 (en) 2010-07-22 2012-01-26 The Procter & Gamble Company Methods for improving the appearance of hyperpigmented spot(s) using an extract of laminaria saccharina
US8114475B2 (en) 2002-07-26 2012-02-14 Philip Morris Usa Inc. Adsorbents for smoking articles comprising a non-volatile organic compound applied using a supercritical fluid
US20120082629A1 (en) 2010-09-01 2012-04-05 Basf Se Associative Thickeners For Aqueous Preparations
US20120093755A1 (en) 2010-10-15 2012-04-19 Maneworx Inc. Compositions and methods for treating keratin based fibers
US8173143B2 (en) 2005-06-02 2012-05-08 Tecco Michelle A Personal skin care compositions containing anti-flammatory and anti-microbial agents
US8183232B2 (en) 2003-02-21 2012-05-22 Teikoku Seiyaku Co., Ltd. Therapeutic agent for hemorrhoidal disease
WO2012077120A2 (en) 2010-12-09 2012-06-14 Y&B Mother's Choice Ltd. Natural formulations
US8206749B1 (en) 1999-02-26 2012-06-26 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
WO2012092528A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP1693050B1 (en) 2005-02-02 2012-07-11 Unilever PLC Care product for skin and/or hair, and the use thereof
US20120189684A1 (en) 2009-07-17 2012-07-26 Reckitt Benckiser Healthcare International Limited Skincare Compositions
US20120201857A1 (en) 2010-03-17 2012-08-09 Pankaj Modi Transdermal delivery system for therapeutics
US8242169B2 (en) 2006-07-04 2012-08-14 Showa Denko K.K. Emulsion composition
WO2012109152A1 (en) 2011-02-07 2012-08-16 Professional Compounding Centers Of America, Ltd. Permeation enhancers for topical formulations
US20120263660A1 (en) 2011-04-18 2012-10-18 Pop Test Cortisol Llc Hair Loss Treatment
EP2120845B1 (en) 2007-02-21 2012-10-24 ROVI Cosmetics International GmbH Nanoparticles for use in cosmetic and dermatological formulations
US20120283233A1 (en) 2010-02-05 2012-11-08 Paul David Gavin Carrier composition
US8309109B2 (en) 2006-06-30 2012-11-13 Hakuto Co., Ltd. Cosmetic and method for production thereof
US20120289590A1 (en) 2011-05-11 2012-11-15 Gerry Ritterman Hair cosmetic composition
EP1370241B1 (en) 2001-02-28 2012-11-21 Neopharm Co., Ltd. Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same
US20120316144A1 (en) 2010-02-25 2012-12-13 Hideo Minobe Antifungal agent
US8337870B2 (en) 2009-12-15 2012-12-25 Young Pharmaceuticals, Inc. Low toxicity topical active agent delivery system
US20130005774A1 (en) 2009-02-25 2013-01-03 Loupenok Leon Topical foam composition
US8361520B2 (en) 2010-10-08 2013-01-29 Palmer Debbie M Antioxidant skin care compositions
US8366688B2 (en) 2005-07-04 2013-02-05 Fischer Pharmaceuticals Ltd. Non-discoloring sterilized wipe
US8372383B2 (en) 1999-10-28 2013-02-12 Medidermis Ltd Agent for inducing hair growth containing extracts of saw palmetto and swertia
EP1545499B1 (en) 2002-07-20 2013-02-20 Daehwa Pharm. Co., Ltd. Composition for solubilization of paclitaxel and preparation method thereof
US20130079395A1 (en) 2010-06-10 2013-03-28 Glaxosmithkline Biologicals S.A. Novel process
EP2214631B1 (en) 2007-12-05 2013-04-03 Henkel AG & Co. KGaA Hair shampoo having a surfactant/thickening combination
US20130090279A1 (en) 2011-10-07 2013-04-11 The Procter & Gamble Company Shampoo Composition Containing a Gel Network
WO2013065051A1 (en) 2011-11-01 2013-05-10 Naveh Pharma (1996) Ltd. Formulation and device for treating ceruminosis
EP1627667B2 (en) 2004-08-02 2013-05-22 L'Oréal SA Water-in-oil emulsion comprising a non-volatile non-silicon oil, cationic and non-ionic surfactants, and an alkyl monoglycoside or an alkyl polyglycoside
US8476316B2 (en) 2010-12-15 2013-07-02 Olatec Industries Llc 3-methanesulfonylpropionitrile for treating inflammation and pain
US8506938B2 (en) 2011-08-26 2013-08-13 Hsien-Wen Lin Compound applying to skin and a method making the same
US8518424B2 (en) 2001-08-17 2013-08-27 Fuji Xerox Co., Ltd. Resin powder for dermatologic composition, skin cleansing agent and cosmetic composition using the powder, and preparation processes of the powder
US20130224268A1 (en) 2012-02-27 2013-08-29 Newgen Biopharma Corp. Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same
US20130231317A1 (en) 2011-07-19 2013-09-05 Michael S. Riepl Dhea bioadhesive controlled release gel
WO2013139808A1 (en) 2012-03-19 2013-09-26 Coty Germany Gmbh Cosmetic skin composition with soothing effect and its use
WO2013139812A1 (en) 2012-03-19 2013-09-26 Coty Germany Gmbh Cosmetic skin composition with soothing effect and its use
EP2649986A2 (en) 2012-02-22 2013-10-16 Ignacio Umbert Millet Cosmetic composition for rejuvenating the skin and corresponding method and uses
EP2650356A1 (en) 2010-12-09 2013-10-16 University of Tsukuba Novel microorganism having high squalene-producing ability, and method for producing squalene by means of same
US20130277307A1 (en) 2009-06-19 2013-10-24 Aquaporin A/S Biomimetic membranes and uses thereof
EP2662074A1 (en) 2012-05-08 2013-11-13 Advanced BioNutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
US8586111B2 (en) 2006-09-15 2013-11-19 Calvin Garris Method of applying a protective film over natural hair or scalp prior to application of bonding glue
US8617579B2 (en) 2012-04-16 2013-12-31 Conopco, Inc. Pre-blended mixtures of specific naturally sourced liquid materials structured with naturally sourced high melting point structuring material
US20140004176A1 (en) 2010-12-29 2014-01-02 Strategic Science & Techologies Delivery of treatments transdermally for fungal infections and other indications
US20140004177A1 (en) 2010-12-29 2014-01-02 Strategic Science & Technologies, Llc Cox-2 inhibitors and related compounds, and systems and methods for delivery thereof
US8623330B2 (en) 2010-03-18 2014-01-07 Precision Dermatology, Inc. Emollient foams for treatment of seborrheic dermatitis
EP2145946B1 (en) 2008-07-16 2014-01-08 Daicel Chemical Industries, Ltd. Detergent Composition
US20140010866A1 (en) 2010-12-29 2014-01-09 Strategic Science & Technologies, Llc Methods and systems for treatment of migraines and other indications
JP2014500853A (en) 2010-10-05 2014-01-16 ルブリゾル アドバンスド マテリアルズ, インコーポレイテッド Acrylate copolymer thickener
US8642659B2 (en) 2008-06-27 2014-02-04 Evonik Goldschmidt Gmbh Hair treatment product and hair after-treatment product containing ether guanidines as active substances, for protecting from damage caused by chemical treatment and for repairing already damaged hair
US20140037772A1 (en) * 2011-02-09 2014-02-06 Wendy Lien Cosmetic or Pharmaceutical Formulation
WO2014027370A1 (en) 2012-08-16 2014-02-20 Gencor Armats Biotek Pvt. Ltd Herbal preparation for stimulation of hair growth, control of hair fall, dandruff and infections thereof using ageratum spp.
US8697043B1 (en) 2013-01-08 2014-04-15 Chattem, Inc. Odor suppression of volatile organic analgesic compounds and method of use
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
WO2014071354A1 (en) 2012-11-05 2014-05-08 Hercules Incorporated Composition comprising conditioning and/or styling polymer
WO2014076533A1 (en) 2012-11-19 2014-05-22 Vi.Rus Srl Unipersonale Composition of a cleansing foam based on natural extracts for the cleansing of the anal area
US20140154200A1 (en) 2011-07-21 2014-06-05 Rhodia Operations Guar hydroxypropyltrimethylammonium chloride and uses thereof in hair treatment compositions
US8765158B2 (en) 2009-11-25 2014-07-01 Kao Corporation W/O emulsion cosmetic
US20140186284A1 (en) 2012-12-27 2014-07-03 L'oreal Conditioning compositions for keratinous substrates
US20140187518A1 (en) 2012-12-28 2014-07-03 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
EP2155888B1 (en) 2007-05-24 2014-07-09 Loders Croklaan B.V. Process for producing compositions comprising tocopherols and tocotrienols
US8808759B1 (en) 2013-09-25 2014-08-19 Chattem, Inc Stabilized colloidal preparations, pre-mix and process for preparing skin care compositions, improved skin care composition, method for treating the skin
WO2014134620A1 (en) 2013-03-01 2014-09-04 Envy Medical, Inc. Acne solution
US20140271940A1 (en) 2013-03-14 2014-09-18 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
US20140271506A1 (en) 2013-03-15 2014-09-18 The Procter & Gamble Company Cosmetic Compositions and Methods For Inhibiting Melanin Synthesis
US20140271949A1 (en) 2013-03-15 2014-09-18 The Iams Company Composition and Method for Preventing, Reducing, Alleviating or Treating Idiopathic Vomiting
WO2014152382A1 (en) 2013-03-15 2014-09-25 Strategic Science & Technologies, Llc Transdermal delivery of sildenafil and other phosphodiesterase type 5 inhibitors
US20140294921A1 (en) 2010-12-09 2014-10-02 Sigma-Tau Industrie Famaceutiche Riunite S.P.A. Composition for tipical use for treating skin disorders
WO2014162280A1 (en) 2013-04-05 2014-10-09 Fuber Limited Emulsifying additive for forming emulsions of water in pure fuel oil or in mixtures containing mainly fuel oil and method for its production
US20140314911A1 (en) 2013-04-18 2014-10-23 Shandong Shenghai Health Care Products Co., Ltd. Deep-Sea Fish Oil Capsule and its Preparation Method
US8871190B2 (en) 2009-04-25 2014-10-28 Sergeant's Pet Care Products, Inc. Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
WO2014179520A1 (en) 2013-05-01 2014-11-06 The Procter & Gamble Company Cosmetic compositions and methods for inhibiting melanin synthesis
US20140350269A1 (en) 2013-04-29 2014-11-27 Glycerosolution Química Ltda. Acetals Esters Produced from Purified Glycerin for Use and Application as Emollients, Lubricants, Plasticizers, Solvents, Coalescents, Humectant, Polymerization Monomers, Additives to Biofuels
US20140348873A1 (en) 2013-05-22 2014-11-27 Professional Compounding Centers Of America Urea-Silicone Gel for Hyperkeratosis Treatment
US8906349B2 (en) 2009-08-12 2014-12-09 Colgate-Palmolive Company Oral care composition
US8911774B2 (en) 2009-05-18 2014-12-16 Cellhealth Technologies Ltd. Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use
EP2179047B1 (en) 2007-08-10 2015-01-14 Bernd Fabry Lipophilic preparations
US8957112B2 (en) 2006-12-21 2015-02-17 Galderma Research & Development Cream gels comprising at least one retinoid and benzoyl peroxide
EP2839833A1 (en) 2012-04-20 2015-02-25 Biolab Sanus Farmacêutica Ltda. Topical pharmaceutical composition, method for producing the topical pharmaceutical composition, use of the topical pharmaceutical composition and method for the topical treatment of psoriasis, atopic dermatitis or chronic eczema
EP2842607A1 (en) 2013-09-02 2015-03-04 Symrise AG A skin and/or hair whitening mixture
WO2015030702A2 (en) 2013-08-26 2015-03-05 Keith Desanto High purity rhamnolipid cosmetic application
US20150080265A1 (en) 2013-09-18 2015-03-19 The Werc Shop, LLC Terpene-based compositions, processes, methodologies for creation and products thereby
US20150086522A1 (en) 2013-09-23 2015-03-26 Michael Todd True Organics Lp Formulation containing herb infused aloe
WO2015043931A1 (en) 2013-09-25 2015-04-02 Unilever Plc Method for evaluating the lubrication and/or friction of hair
WO2015068052A2 (en) 2013-10-31 2015-05-14 Full Spectrum Laboratories, Ltd. Terpene and cannabinoid formulations
US20150139929A1 (en) 2011-12-22 2015-05-21 Nicholas John Dixon Personal care composition and method of use thereof
WO2015074667A2 (en) 2013-11-25 2015-05-28 Unigroup Aps Composition for dermatitis
EP2878304A1 (en) 2013-11-26 2015-06-03 Aboca S.p.A. Societa' Agricola New fractions of chamomile extracts and uses thereof
EP2529726B1 (en) 2010-01-29 2015-06-03 Shiseido Company, Ltd. Oil-in-water emulsion sunscreen cosmetic composition
WO2015083174A1 (en) 2013-12-08 2015-06-11 Y&B Mother's Choice Ltd. Preparations for suppressing or attenuating ocular irritancy
US9056065B1 (en) 2014-01-27 2015-06-16 Shawnee Green-Tucker Hair composite
US20150174182A1 (en) 2013-12-20 2015-06-25 Pfizer Inc Pre moistened wipes for use in treating anal rectal irritations and disorders
US20150177221A1 (en) 2013-12-19 2015-06-25 L'oreal Simulated contaminated skin formulation
US20150182448A1 (en) 2013-12-31 2015-07-02 Shang Chen Mei Bang (Beijing) Biotechnology Co., Ltd. Traditional chinese medicine composition for dispelling wringles and black eye and its preparation method
US20150182447A1 (en) 2013-10-04 2015-07-02 Soung Lyul Park Method for improving skin condition comprising six steps and system therefor
US9101554B2 (en) 2012-05-17 2015-08-11 Eiji Sakuma Spray composition for companion animal bodies
US9119974B2 (en) 2011-03-04 2015-09-01 Ahmed H. Al-Qahtani Skin cream
WO2015138479A1 (en) 2014-03-10 2015-09-17 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
US20150265526A1 (en) 2014-03-19 2015-09-24 Beaute Pacifique Aps Topical composition for the cosmetic treatment of the human skin
WO2015140138A1 (en) 2014-03-17 2015-09-24 Glaxosmithkline Biologicals Sa Oil/surfactant mixtures for self-emulsification
US9155915B2 (en) 2009-07-27 2015-10-13 Dermadoctor, Inc. Moisturizing retinol composition
EP2700413B1 (en) 2012-08-20 2015-10-14 Bionoox Suisse SA Composition comprising dihydroquercetin, alpha-tocopherol and bisabolol
US20150297504A1 (en) * 2012-12-11 2015-10-22 Jean-Marie Botto Cosmetic use of a carob seed extract as a slimming active agent
US9167839B1 (en) 2011-03-08 2015-10-27 Mark S. Bezzek Multivitamin-mineral regimens for longevity and wellness
WO2015164290A1 (en) 2014-04-23 2015-10-29 The Procter & Gamble Company Cosmetic compositions having reduced irritation
WO2015164433A1 (en) 2014-04-21 2015-10-29 Envy Medical, Inc. Acne solution
US9180074B2 (en) 2009-11-25 2015-11-10 Kao Corporation O/W emulsion cosmetic
WO2015175333A1 (en) 2014-05-16 2015-11-19 Restorsea, Llc Biphasic cosmetic
US20160000682A1 (en) 2014-07-02 2016-01-07 Geoffrey Brooks Consultants Llc Peptide-Based Compositions and Methods of Use
US20160008297A1 (en) 2012-08-23 2016-01-14 B.R.A.I.N. Biotechnology Research And Information Network Ag Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
EP2977044A1 (en) 2013-03-19 2016-01-27 Senju Pharmaceutical Co., Ltd. Two-layer separation-type eye drop containing squalane
WO2016012587A1 (en) 2014-07-25 2016-01-28 Biosynth S.R.L. Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
WO2016012110A1 (en) 2014-07-22 2016-01-28 Bio.Lo.Ga. S.R.L. Composition comprising an ester of alpha-tocopherol for prevention and treatment of allergic rhinitis
WO2016012757A1 (en) 2014-07-22 2016-01-28 Perachem Limited Hair conditioning compositions
WO2016012797A1 (en) 2014-07-25 2016-01-28 Croda International Plc Anti-dandruff composition
US20160030553A1 (en) 2013-03-19 2016-02-04 Biotech Tools S.A. Allergen preparation
WO2016018315A1 (en) 2014-07-30 2016-02-04 Younique, Llc Formulations, methods and devices for periorbital skin rejuvenation
WO2016040757A1 (en) 2014-09-12 2016-03-17 The Procter & Gamble Company Cosmetic compositions and methods for inhibiting melanin synthesis
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
US20160081895A1 (en) 2014-09-18 2016-03-24 Stiefel Laboratories, Inc. Novel formulations
US9295632B1 (en) 2014-12-17 2016-03-29 L'oreal Compositions comprising latex polymers and methods for altering the color of hair
US9295622B2 (en) 2011-12-06 2016-03-29 Mary Kay Inc. Substantive sunscreen formulation
EP2604298B1 (en) 2011-12-15 2016-03-30 DEMO SA Pharmaceutical Industry Multipurpose solutions for contact lens care comprising chamomile
US9303231B2 (en) 2012-05-29 2016-04-05 Roquette Freres Method for continuously enriching an oil produced by microalgae with ethyl esters of DHA
US9320744B2 (en) 2011-10-19 2016-04-26 Dhea Llc DHEA bioadhesive controlled release gel
US9327021B2 (en) 2010-11-15 2016-05-03 Sanofi Pasteur Limited Immunogenic compositions
EP3015114A1 (en) 2014-06-18 2016-05-04 Institute Of Process Engineering Chinese Acadamy Of Sciences Oil-in-water emulsion containing no surfactant and use thereof
US9346722B2 (en) 2012-04-16 2016-05-24 Roquette Freres Method for refining squalene produced by microalgae
EP3031322A1 (en) 2013-10-02 2016-06-15 Kyoyu Agri Co. Ltd. Composition comprising harmful arthropod-attracting substance formed from plant-derived components and analogs thereof
US20160175238A1 (en) 2014-12-19 2016-06-23 L'oreal Hair cosmetic composition containing a polyurethane latex polymer and a silicone-organic polymer compound
US20160200701A1 (en) 2013-08-30 2016-07-14 Inventure Renewables, Inc. Methods for the separation or purification of vitamin e, tocopherols and tocotrienols from lipid mixtures
WO2016112201A1 (en) 2015-01-07 2016-07-14 Strategic Science & Technologies, Llc Techniques and systems for transdermal delivery involving treatment of psoriasis, skin cancer, and other indications
US9399009B1 (en) 2012-10-05 2016-07-26 Clark Pharmaceuticals, Llc Composition and method of treating skin conditions
WO2016118907A1 (en) 2015-01-22 2016-07-28 Bcs Business Consulting Services Pte Ltd. Formulations of hydrophilic compounds
US20160250137A1 (en) 2006-05-11 2016-09-01 Air Products And Chemicals, Inc. Personal care compositions containing functionalized polymers
WO2016138505A1 (en) 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
WO2016144675A1 (en) 2015-03-06 2016-09-15 Medimmune, Llc Vaccine dose and use thereof
US9446089B1 (en) 2011-09-20 2016-09-20 Aja Henderson Oil blend for skin treatment
EP1485066B1 (en) 2002-03-12 2016-09-21 Ethypharm Composition having gelling properties for the prolonged delivery of bioactive substances
US20160287484A1 (en) 2013-11-15 2016-10-06 Emma Neame Dry Shampoo Composition for Hair
US20160316750A1 (en) 2013-12-17 2016-11-03 Simon Fraser University Compounds, Compositions and Methods for Attracting and/or Arresting Bed Bugs
US20160317480A1 (en) 2015-04-28 2016-11-03 Nicholas Adam Brockman Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness
WO2016178660A1 (en) 2014-05-02 2016-11-10 Hercules Inncorporated Personal care composition for a keratin substrate comprising conditioning and/or styling polymer
US20160324914A1 (en) 2015-05-05 2016-11-10 Tocol Pharmaceuticals, Llc Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation
US20160324754A1 (en) 2015-05-06 2016-11-10 Getco Llc Shave cream formulation
US20160330957A1 (en) 2013-12-31 2016-11-17 Universidad De La Frontera Fungicidal composition for controlling phytopathogenic diseases, comprising a mixture of the volatile compounds ethanol, 3-methylbutanol, isobutyl acetate, isoamyl acetate and alpha-bisabolol; and the use thereof for inhibiting the growth of the pathogenic fungus botrytis cinerea
US9504659B2 (en) 2006-01-13 2016-11-29 Sanofi Pasteur Sa Thermoreversible oil-in-water emulsion
US20160356798A1 (en) 2013-12-20 2016-12-08 Metabolon, Inc. Biomarkers of de novo lipogenesis and methods using the same
WO2016196989A1 (en) 2015-06-03 2016-12-08 Senju Usa, Inc. Topical composition
US20160367457A1 (en) 2014-02-13 2016-12-22 Basf Se Capryloyl alanine ethylester as a penetration enhancer
US9526681B2 (en) 2012-12-03 2016-12-27 Colgate-Palmolive Company Compositions and methods for treating dental caries
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
US20170000707A1 (en) 2015-07-02 2017-01-05 Alfa Parf Group S.P.A. Method for Dyeing Keratin Fibres
US9539446B2 (en) 2010-05-14 2017-01-10 David J. Schenider Low chlorine odor control compositions
US20170014314A1 (en) 2014-02-10 2017-01-19 Bbr Liquid cosmetic composition suitable for changing temporarily keratinic fibers color - related method
WO2017034384A1 (en) 2015-08-24 2017-03-02 Rīgas Stradiņa Universitāte Epidermal lipid barrier restoring cream for facial skin, neck and decollete area for metabolic syndrome patients
WO2017037534A1 (en) 2015-09-06 2017-03-09 Prestigio Ltd. Topical compositions for treatment of psoriasis
US20170096418A1 (en) 2015-10-01 2017-04-06 Senomyx, Inc. Compounds useful as modulators of trpm8
WO2017059136A1 (en) 2015-10-02 2017-04-06 Amyris, Inc. Compositions containing bio-based farnesene or compounds derived therefrom and their use in consumer and industrial products
EP3159044A1 (en) 2015-10-23 2017-04-26 C&C International Co., Ltd. Long-lasting powder essence composition with improved coloring and skin feeling and preparation method thereof
WO2017068505A1 (en) 2015-10-20 2017-04-27 Codex V S.R.L. Non-saponifiable compounds from natural lipids for use in the treatment and the readjustment of the steroidal balance suffering from permanent chronic modification
US20170119658A1 (en) 2015-11-01 2017-05-04 Justin Turvey Preparation for enhanced fingerprint image formation on a transparent surface of a live scan device
US9642795B2 (en) 2010-11-12 2017-05-09 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
US20170128355A1 (en) 2015-11-10 2017-05-11 Vincent C. Giampapa Topical composition for skin treatment to reduce lines and wrinkles of the face and body using a dual dna repair mechanism to address damage caused by aging and ultra-voilet induced damage to the skin with combination of skin turgor enhancement compounds
US20170128522A1 (en) 2015-10-14 2017-05-11 Paul Gavaris Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
EP2467120B1 (en) 2009-08-20 2017-05-24 Kneipp GmbH Composition for cleaning and/or caring for the skin, comprising an ethanolic and aqueous hydrodispersible mint composition
WO2017087924A1 (en) 2015-11-20 2017-05-26 Isp Investments Llc Personal care compositions comprising copolymers of cationic monomers and acryloyl lactam based monomers, process for the same and method of use
USRE46441E1 (en) 2009-12-03 2017-06-20 Novartis Ag Circulation of components during homogenization of emulsions
WO2017108902A1 (en) 2015-12-23 2017-06-29 Novartis Ag Oil-in-water emulsions including retinoic acid
US20170209383A1 (en) 2014-10-08 2017-07-27 Alva-Amco Pharmacal Companies, Inc. Composition for nap promotion
US20170216177A1 (en) 2015-05-18 2017-08-03 Angelo Perry Thrower Hair regrowth treatment and growth stimulant
US20170216368A1 (en) 2014-08-25 2017-08-03 Muciderm S.A. Pharmaceutical composition for preventing, treating, and curing psoriasis including snail slime, chamomile, and honey
EP2774601B1 (en) 2013-03-06 2017-08-16 Oleos Cosmetic and/or dermatological product made of cork extract, from at least one portion of the tree that provides cork, and at least one natural greasy substance, method for preparing same and composition containing same
WO2017161036A1 (en) 2016-03-14 2017-09-21 Isp Investments Llc Personal care composition for a keratin substrate comprising conditioning, color protecting and styling polymer
WO2017161387A1 (en) 2016-03-18 2017-09-21 Reid Christopher Brian Compositions of natural extracts and use thereof in methods for preventing or treating diseases
EP2589693B1 (en) 2010-06-29 2017-10-04 Kao Corporation Nanofiber
US20170281526A1 (en) 2016-03-31 2017-10-05 L'oreal Method for providing a customized skin care product to a customer
US20170281492A1 (en) 2016-03-31 2017-10-05 L'oreal Method and composition for treating skin conditions
US20170281690A1 (en) 2014-10-10 2017-10-05 Muciderm S.A. Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, chamomile and propolis
US9782333B2 (en) 2015-01-21 2017-10-10 Chattem Inc. Oral composition for xerostomia
EP2225003B1 (en) 2007-07-03 2017-10-11 L'Oréal Methods and kits for permanently coloring hair using persulfates, perborates or percarbonates
US20170290799A1 (en) 2014-10-22 2017-10-12 Bio.Lo.Ga. S.R.L. Pharmaceutical composition for use in increasing the trophism of nasal mucosa
US9789042B2 (en) 2011-03-25 2017-10-17 Kokyu Alcohol Kogyo Co., Ltd. Damaged hair improving agent and process for improving damaged hair using the same
US9789099B2 (en) 2012-10-15 2017-10-17 Beiersdorf Ag Cosmetic or dermatological preparation for prophylaxis and/or treatment of atopic dermatitis
EP3231414A2 (en) 2016-03-21 2017-10-18 Cristiano Ravetta Spray dispenser device and composition for topical use comprising a c14 or c12 plant alkane
US9801900B2 (en) 2013-11-22 2017-10-31 Mary Kay Inc. Compositions for sensitive skin
US9801796B2 (en) 2014-02-06 2017-10-31 Robertet S.A. Use of parfumery compounds against hair regrowth
EP2392311B1 (en) 2010-06-01 2017-11-01 Intercos S.p.A. Process for obtaining a solid, compact powder cosmetic product.
US9822243B2 (en) 2009-04-22 2017-11-21 Dr. Suwelack Skin & Health Care Ag Freeze-dried composition
US9827176B2 (en) 2014-11-17 2017-11-28 Shirley Johnson Antifungal deodorant
WO2017204618A1 (en) 2016-05-23 2017-11-30 Attest Research Sdn Bhd A composition for preventing or mitigating dementia
US20170348203A1 (en) 2016-06-07 2017-12-07 Henkel Ag & Co. Kgaa Stable cosmetic cleansing compositions containing cold cream
US20170354585A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US9849071B2 (en) 2011-12-19 2017-12-26 L'oreal Composition for the oxidation dyeing of keratin fibres, comprising particular fatty alcohols, a liquid fatty substance and a cationic polymer
US20170368376A1 (en) 2016-06-24 2017-12-28 Colgate-Palmolive Company Oral Care Compositions and Methods of Use
US9855346B2 (en) 2014-11-06 2018-01-02 Chang Gung University Of Science And Technology Fluorescent dye compositions and uses thereof
WO2018000060A1 (en) 2016-06-30 2018-01-04 L'oreal Anti-acne sunscreen composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9968535B2 (en) * 2007-10-26 2018-05-15 The Procter & Gamble Company Personal care compositions comprising undecyl sulfates
US20090238905A1 (en) * 2008-03-20 2009-09-24 Symrise, Inc. Inflammation reducing action of synergistic mixtures of bisabolol and ginger extracts
US9237993B2 (en) * 2014-01-24 2016-01-19 Combe Incorporated Gradual haircolor compositions and methods of using the same

Patent Citations (430)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661475A (en) * 1983-09-30 1987-04-28 Diamalt Aktiengesellschaft Gelling agents and thickeners based on Cassia-galactomannans
US5306489A (en) * 1992-07-24 1994-04-26 Revlon Consumer Products Corporation Hair care products containing N-alkoxyalkylamides
US5759527A (en) 1996-10-02 1998-06-02 Colgate-Palmolive Company Hair conditioning composition
US6193986B1 (en) 1997-02-25 2001-02-27 The Nisshin Oil Mills, Ltd. Oily composition with increased stability and process for producing the same
US5863546A (en) 1997-03-02 1999-01-26 Swinehart; James M Cosmetic composition
US6268355B1 (en) 1997-06-25 2001-07-31 Teikoku Seiyaku Co., Ltd. Stable aspirin-containing preparations for external use
EP1014916B2 (en) 1997-08-18 2011-06-15 Neubourg Skin Care GmbH & Co. KG Foaming skin cream, uses thereof and a method for producing the same
US6444213B1 (en) 1997-08-28 2002-09-03 Daikin Industries Ltd. Cosmetics with hydrofluoroether (HFE)
US6165493A (en) 1997-10-22 2000-12-26 New York Blood Center, Inc. "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
EP0978270B1 (en) 1997-10-31 2006-02-01 Shiseido Company Limited Emulsified cosmetic face pack
US6113891A (en) 1997-11-19 2000-09-05 Hercules Incorporated Fluidized polymer suspensions of cationic polysaccharides in emollients and use thereof in preparing personal care compositions
US7393630B2 (en) 1997-12-16 2008-07-01 Novartis Vaccines And Diagnostics, Inc. Use of microparticles combined with submicron oil-in-water emulsions
EP1061799B1 (en) 1998-03-12 2004-04-28 THE PROCTER &amp; GAMBLE COMPANY Tissue paper having antimicrobial skin lotion
EP0947491B1 (en) 1998-04-01 2004-05-12 Nippon Petrochemicals Company, Limited Method for producing highly pure squalane
US6406708B1 (en) 1998-05-12 2002-06-18 Interhealth Ab Therapeutic compositions
EP1077675B1 (en) 1998-05-12 2005-08-24 InterHealth AB Compositions for the treatment of acne
EP1000603B1 (en) 1998-10-01 2005-02-09 Beiersdorf Aktiengesellschaft Use of surface-active citric acid esters for stabilizing flavones, flavanones or flavonoids, and synergistic mixtures, cosmetic and dermatological preparations containing them
US7182939B2 (en) 1998-10-26 2007-02-27 Shiseido Company, Ltd. Hair tonic composition
US6436367B1 (en) 1998-12-21 2002-08-20 Generex Pharmaceuticals Inc. Aerosol formulations for buccal and pulmonary application
EP1140019B1 (en) 1998-12-21 2003-06-25 Generex Pharmaceuticals Inc. Aerosol formulations for buccal and pulmonary application
US6375975B1 (en) 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US8206749B1 (en) 1999-02-26 2012-06-26 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
US6350432B1 (en) 1999-03-19 2002-02-26 Generex Pharmaceuticals Incorporated Pressurized container having an aerosolized pharmaceutical composition
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US7078050B2 (en) 1999-06-01 2006-07-18 Normajean Fusco Composition for topical treatment
US6896897B2 (en) 1999-07-23 2005-05-24 Alwyn Company, Inc. Flexible applicator for applying oil-in-water emulsion with improved stability
US6281236B1 (en) 1999-07-23 2001-08-28 Alwyn Company, Inc. Oil-in-water emulsion with improved stability
EP1116483B1 (en) 1999-07-27 2010-12-08 Shiseido Company Limited Oil-in-water emulsion composition
US8372383B2 (en) 1999-10-28 2013-02-12 Medidermis Ltd Agent for inducing hair growth containing extracts of saw palmetto and swertia
EP1097695B1 (en) 1999-11-08 2002-09-18 L'oreal Composition containing an aqueous suspension of particles of an organopolysiloxane elastomer and cosmetical uses thereof
US20030102004A1 (en) 2000-01-19 2003-06-05 Yoshihiro Hirata Hair styling method
EP1252836B1 (en) 2000-01-19 2006-08-09 Phild Co., Ltd. Improved hair styling method
US7858840B2 (en) 2000-01-25 2010-12-28 Uni-Charm Corporation Absorbent article containing skin-protective ingredient
US20030039619A1 (en) 2000-01-28 2003-02-27 Joachim Bunger Galenic formulation
US20030113315A1 (en) 2000-02-24 2003-06-19 Yoshihiro Hirata Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
US7883729B2 (en) 2000-03-20 2011-02-08 Laboratories Expanscience Natural vegetable oil concentrated in unsaponifiable matters as food ingredient
US20070166241A1 (en) 2000-04-21 2007-07-19 Baker Amy E Salicylic acid acne spray formulations and methods for treating acne with same
US20100227008A1 (en) 2000-04-21 2010-09-09 Nature's Cure Salicylic acid acne spray formulations and methods for treating acne with same
US20040072915A1 (en) 2000-04-27 2004-04-15 Andre Rougereau Novel medicines based on sesquiterpene mixtures
US7297717B2 (en) 2000-04-27 2007-11-20 Kao Corporation Emulsion cosmetic
EP1152022B1 (en) 2000-05-05 2007-02-28 Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. Inverse latex based on squalane or hydrogenated polyisobutene and cosmetic compositions, dermocosmetics, dermopharmaceuticals or pharmaceutical compositions containing them
US6673861B2 (en) 2000-05-05 2004-01-06 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Inverse latices self-invertible with respect to white mineral oils, squalane, hydrogenated polyisobutene, isohexadecane or isododecane and cosmetic, democosmetic, dermopharmaceutical or pharmaceutical compositions comprising them
US20010053801A1 (en) 2000-05-05 2001-12-20 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Inverse latexes based on white mineral oil, squalene or hydrogenated polyisobutene, cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions containing them
US20060029627A1 (en) 2000-07-26 2006-02-09 Yuuzou Tsuchida Antipruritic composition and wound-healing-promoting composition
US20030185920A1 (en) 2000-08-03 2003-10-02 Siro Passi Sebum-like preparation to be used as lipidic component in cosmetics
US6312675B1 (en) 2000-09-14 2001-11-06 Jeffrey Alan Deane Hair cleaner
US20040013618A1 (en) 2000-09-28 2004-01-22 Siro Passi Cosmetic formulation
EP1192934B1 (en) 2000-09-30 2006-10-18 Beiersdorf Aktiengesellschaft Emulsion preparations of the w/o type with an increased water content based on lipidic components
EP1222915B1 (en) 2001-01-16 2005-09-07 Uni-Charm Corporation Wet wiper impregnated with plant extracts
US20020176876A1 (en) 2001-01-23 2002-11-28 Harris Dennis H. Topical therapeutic skin care system
EP1353645B1 (en) 2001-01-24 2007-09-26 Cortex Technology Aps Method for the production and use of a cream containing vitamin-a.
US6471954B2 (en) 2001-01-24 2002-10-29 Cortex Technology Aps Method for the production and use of a cream containing vitamin-A
US20020143063A1 (en) 2001-01-29 2002-10-03 Alvarado Robert M. Hair conditioner composition that is non-irritating to the eyes
US6649151B2 (en) 2001-02-06 2003-11-18 Coty Inc. Cosmetic formulation
US7427407B2 (en) 2001-02-28 2008-09-23 Kao Corporation Cosmetics
EP1370241B1 (en) 2001-02-28 2012-11-21 Neopharm Co., Ltd. Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same
US20030003069A1 (en) 2001-04-04 2003-01-02 Carson John C. Multiple phase foaming personal cleansing products
US20020155083A1 (en) 2001-04-19 2002-10-24 Morris Mann Dermal regeneration methods and compositions related thereto in conjunction with laser phototherapy, microdermabrasion and epidermabrasion
US20040186042A1 (en) 2001-07-09 2004-09-23 Gerhard Schmaus Iso-$g(b)-bisabolol as fragrance and aroma substance
US6699464B1 (en) 2001-07-30 2004-03-02 Stiefel Laboratories, Inc. Compositions for treatment of hyperpigmentation and methods for making and using such compositions
US7326410B2 (en) 2001-08-06 2008-02-05 Kao Corporation Hair conditioner compositions
US6923954B2 (en) 2001-08-06 2005-08-02 Kao Corporation Conditioner
US8518424B2 (en) 2001-08-17 2013-08-27 Fuji Xerox Co., Ltd. Resin powder for dermatologic composition, skin cleansing agent and cosmetic composition using the powder, and preparation processes of the powder
US20050175646A1 (en) 2001-10-30 2005-08-11 Philippe Catroux Cosmetic composition that mimics sebum and the use thereof
US20030093045A1 (en) 2001-11-13 2003-05-15 Erdman Carol L. Absorbing article having zoned areas of hydrophilicity
US20020048603A1 (en) 2001-12-07 2002-04-25 Fred Burmeister Hydrogel composition
US20050152993A1 (en) 2002-01-25 2005-07-14 Mariana De Oliveira Composition for and method of treatment for skin ailments
US7314634B2 (en) 2002-02-22 2008-01-01 Steven Hernandez Use of polyphenols to treat skin conditions
US20030165585A1 (en) 2002-02-25 2003-09-04 Mann Maria A. Xanthine-containing compositions for oral administration and uses related thereto
EP1485066B1 (en) 2002-03-12 2016-09-21 Ethypharm Composition having gelling properties for the prolonged delivery of bioactive substances
US7262180B2 (en) 2002-04-09 2007-08-28 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
US20080015155A1 (en) 2002-04-09 2008-01-17 Sinclair Pharmaceuticals Ltd. Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye
US7956025B2 (en) 2002-04-30 2011-06-07 Cognis Ip Management Gmbh Finished fibers and textiles
US7807188B2 (en) 2002-05-03 2010-10-05 Children's Hospital Medical Center Simulated vernix compositions for skin cleansing and other applications
US7959935B2 (en) 2002-05-03 2011-06-14 Children's Hospital Medical Center Simulated vernix compositions for skin cleansing and other applications
US20060024256A1 (en) * 2002-06-04 2006-02-02 Wells Robert L Shampoo containing a gel network
US6723309B1 (en) 2002-06-10 2004-04-20 Jeffrey Alan Deane Hair cleansing conditioner
US8021674B2 (en) 2002-06-14 2011-09-20 Coty B.V. Cosmetic gel product on the basis of oils and gelling agents
US7906557B2 (en) 2002-06-19 2011-03-15 Maruha Nichiro Seafoods, Inc. Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether
US20050220810A1 (en) 2002-06-25 2005-10-06 Shiseido Company, Ltd. Anti-aging preparation
EP1545499B1 (en) 2002-07-20 2013-02-20 Daehwa Pharm. Co., Ltd. Composition for solubilization of paclitaxel and preparation method thereof
US8114475B2 (en) 2002-07-26 2012-02-14 Philip Morris Usa Inc. Adsorbents for smoking articles comprising a non-volatile organic compound applied using a supercritical fluid
US20040185016A1 (en) 2002-07-30 2004-09-23 Popp Karl F Compositions for treatment of hyperpigmentation and methods for making and using such compositions
US20040057917A1 (en) 2002-09-24 2004-03-25 Hans-Dieter Prentner Pharmaceutical composition for treatment and /or prevention of a light-dermatosis
EP1410784B1 (en) 2002-10-18 2007-02-07 L'oreal Cosmetic composition comprising an oil phase and a naphthopyran dye and method
US20050276767A1 (en) 2002-10-18 2005-12-15 L'oreal Composition containing an oily phase and a naphthopyran dye, cosmetic treatment processes
US20070087744A1 (en) 2003-01-08 2007-04-19 Svein Haglund Method for reducing the time delay in a telephone system
US6723689B1 (en) 2003-01-08 2004-04-20 Becton Dickinson And Company Emollient alcohol skin disinfecting formulation
EP1581052B1 (en) 2003-01-08 2012-06-13 Becton Dickinson and Company An emollient alcohol skin disinfecting formulation
US8183232B2 (en) 2003-02-21 2012-05-22 Teikoku Seiyaku Co., Ltd. Therapeutic agent for hemorrhoidal disease
US20050025847A1 (en) 2003-02-26 2005-02-03 Program For Appropriate Technology In Health Microbicidal compositions and method of use
US20050031571A1 (en) 2003-05-16 2005-02-10 Khaiat Alain V. Topical treatment of ingrown hairs
US7459166B2 (en) 2003-05-28 2008-12-02 Coty B.V. Cosmetic product containing mineral water for remineralizing and rejuvenating the skin
EP1631245B1 (en) * 2003-05-29 2009-01-28 Colgate-Palmolive Company Transparent conditioning shampoo
US20050008604A1 (en) 2003-06-17 2005-01-13 Schultz Thomas M. Modified soy proteins in personal care compositions
EP1493423B1 (en) 2003-06-18 2006-06-14 Goldschmidt GmbH Composition for hair treatment and for the after-treatment of hair for protection against damage by chemical treatment and for the repair of pre-existing damaged hair, comprising alkyl-guanidinium derivatives as active agent
US20040258652A1 (en) 2003-06-18 2004-12-23 Goldschmidt Ag Hair treatment compositions and hair after-treatment compositions for protection against damage by chemical treatment and for the repair of already damaged hair comprising as active substances alkylguanidine compounds
US20040258651A1 (en) 2003-06-18 2004-12-23 Goldschmidt Ag Use of alkylguanidine compounds for the treatment and after-treatment of hair
US20050025817A1 (en) 2003-07-03 2005-02-03 Bhatia Kuljit S. Delivery system for topical medications
WO2005018629A1 (en) 2003-08-12 2005-03-03 Yarbrough William M Treatment for acne vulgaris and method of use
US20050074474A1 (en) 2003-10-03 2005-04-07 The Procter & Gamble Company Topical composition
US20050089488A1 (en) 2003-10-27 2005-04-28 Kim Joo W. Deodorant composition with monocyclic, unsaturated sequiterpene alcohols and glyceryl monoalkyl ethers as synergistic active deodorant agents
US20070264363A1 (en) 2003-11-13 2007-11-15 Compton Deveolopment Ltd Molluscicidal and Anti-Barnacle Compounds
US7247173B2 (en) 2003-12-17 2007-07-24 Henkel Kommandit Gesellschaft Auf Aktien Tinting agent in tubes
EP1696870B1 (en) 2003-12-17 2011-09-21 Henkel AG & Co. KGaA Tinting agent in tubes
US7294153B2 (en) 2003-12-17 2007-11-13 Henkel Kommanditgesellschaft Auf Aktien Caring oxidation coloring agent in a tube
US20050169865A1 (en) 2003-12-19 2005-08-04 Eric Parris Cosmetic composition comprising at least one cationic agent, at least one semi-crystalline polymer and at least one oil, and cosmetic treatment process
US20050158262A1 (en) 2003-12-19 2005-07-21 Eric Parris Cosmetic composition comprising a cationic agent, a polymer comprising a hetero atom and an oil, and cosmetic treatment process
US20070082017A1 (en) 2004-01-10 2007-04-12 Tseng Scheffer C Lipid compositions and methods of use
EP1566175B1 (en) 2004-02-18 2006-10-25 MERCK PATENT GmbH Topical preparation comprising at least one aryloxime and bisabolol
US20050249761A1 (en) 2004-02-18 2005-11-10 Joachim Buenger Topical composition comprising at least one aryl oxime and bisabolol
US20080020004A1 (en) 2004-02-18 2008-01-24 Susanne Birkel Hair-Treatment Agent Comprising Terpolymer Of Vinylpyrrolidone, Methacrylamide And Vinylimidazole And Active Ingredients And Additives
US7829067B2 (en) 2004-03-03 2010-11-09 Bio-Botanica, Inc. Method and composition for treating oral bacteria and inflammation
EP1576882B1 (en) 2004-03-18 2010-10-06 The State Of Israel-Ministry Of Agriculture & Rural Development Pest-impervoius packaging material and pest-control composition
US20080057008A1 (en) 2004-03-18 2008-03-06 Imperial Chemical Industries Plc Metal Oxide Dispersion
US20050226838A1 (en) 2004-04-08 2005-10-13 Thomas Krause Hair treatment compositions containing N-hydroxy-alkyl-O-benzyl chitosans and methods of using same
US20080032384A1 (en) 2004-04-22 2008-02-07 Takehiko Nomura Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton
US20090074888A1 (en) 2004-07-02 2009-03-19 Bhatia Kuljit S Stable cleanser compositions containing sulfur
US20070243147A1 (en) 2004-07-24 2007-10-18 Beiersdorf Ag Skin and/or Hair Composition Containing Compounds for Increasing The Tanning of Skin
US20060024258A1 (en) 2004-08-02 2006-02-02 L'oreal Water-in-oil emulsion comprising a non-volatile non-silicone oil, cationic and nonionic surfactants, and an alkylmonoglycoside or alkylpolyglycoside
EP1627667B2 (en) 2004-08-02 2013-05-22 L'Oréal SA Water-in-oil emulsion comprising a non-volatile non-silicon oil, cationic and non-ionic surfactants, and an alkyl monoglycoside or an alkyl polyglycoside
EP1629865B1 (en) 2004-08-02 2008-10-08 L'oreal Water-in-oil emulsion comprising a non-volatile non-siliconized oil, a cationic surfactant, a polyolfin with polar areas, and an alkylmonoglycosid or an alkylpolyglycoside
US20060057075A1 (en) 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20060051310A1 (en) 2004-08-02 2006-03-09 L'oreal Water-in-oil emulsion comprising a non-volatile non-silicone oil, a cationic surfactant, a polyolefin with polar portion(s), and an alkylmonoglycoside or alkylpolyglycoside
EP1778289B1 (en) 2004-08-03 2011-01-12 Vital Health Sciences Pty Ltd. Carrier for enteral administration
US20070082042A1 (en) 2004-08-06 2007-04-12 Deok-Hoon Park Multiple-layered liposome and preparation method thereof
US20070265353A1 (en) 2004-08-27 2007-11-15 Senju Pharmaceutical Co., Ltd. Eye Drops for the Treatment of Dry Eye
US20060051311A1 (en) 2004-09-04 2006-03-09 Andrea Walter Hair treatment composition containing a combination of at least three different polymers
US7763180B2 (en) 2004-09-07 2010-07-27 Kao Corporation Wrinkle-removing composition
US20060062749A1 (en) 2004-09-16 2006-03-23 Shelton Michael C personal care products incorporating cellulosic fatty acid esters
US20080069898A1 (en) * 2004-11-11 2008-03-20 Smith Christopher F Topical Compositions Comprising Myrica Gale Oil
EP1816998B1 (en) 2004-11-22 2009-03-18 Symrise GmbH & Co. KG Formulations comprising ceramides and/or pseudoceramides and (alpha-)bisabolol for combating skin damage
US20100286102A1 (en) 2004-11-22 2010-11-11 Symrise Gmbh & Co. Kg Formulations comprising ceramides and/or pseudoceramides and (alpha-)bisabolol for combating skin damage
EP1693050B1 (en) 2005-02-02 2012-07-11 Unilever PLC Care product for skin and/or hair, and the use thereof
US7825207B2 (en) 2005-02-02 2010-11-02 Goldschmidt Gmbh Siloxanes containing guanidino groups and use thereof for cosmetic formulations
US8173143B2 (en) 2005-06-02 2012-05-08 Tecco Michelle A Personal skin care compositions containing anti-flammatory and anti-microbial agents
US20080112898A1 (en) 2005-06-20 2008-05-15 Hartmut Schiemann Product release system to atomize polymer-containing cosmetic hair compositions
US20070297992A1 (en) 2005-06-20 2007-12-27 Hartmut Schiemann Product release system to atomize compositions containing hair-conditioning ingredients
US20090098079A1 (en) 2005-06-20 2009-04-16 The Procter & Gamble Company Product release system for atomizing cosmetic hair compositions containing cationic polymers
US8366688B2 (en) 2005-07-04 2013-02-05 Fischer Pharmaceuticals Ltd. Non-discoloring sterilized wipe
US20140178478A1 (en) 2005-07-07 2014-06-26 Sanofi Pasteur Immuno-Adjuvant Emulsion
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
US7744856B2 (en) 2005-10-03 2010-06-29 Biotech Research And Development Corporation Formulations with feruloyl glycerides and methods of preparation
US8241681B2 (en) 2005-10-14 2012-08-14 Symrise Ag Synergistic mixtures of bisabolol and ginger extract
EP1937366B1 (en) 2005-10-14 2011-12-14 Symrise AG Synergistic mixtures of bisabolol and ginger extract
US20090220625A1 (en) 2005-10-14 2009-09-03 Martina Herrmann Synergistic mixtures of bisabolol and ginger extract
US20080171030A1 (en) 2005-11-01 2008-07-17 Juice Beauty Compositions for juice-based moisturizers
US20090170816A1 (en) 2005-11-18 2009-07-02 Farmaleis S.L. Combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer
US20070154439A1 (en) 2006-01-04 2007-07-05 Paula Dorf Cosmetic composition for use around the eyes
US9504659B2 (en) 2006-01-13 2016-11-29 Sanofi Pasteur Sa Thermoreversible oil-in-water emulsion
US20100074853A1 (en) 2006-01-19 2010-03-25 Mary Kay Inc. Compositions Comprising Kakadu Plum Extract Or Acai Berry Extract
US20100008880A1 (en) 2006-05-03 2010-01-14 John Castro Clear Cosmetic Compositions And Methods Of Using
US20160001099A1 (en) 2006-05-03 2016-01-07 John R. Castro Clear Cosmetic Compositions And Methods of Using
US20160250137A1 (en) 2006-05-11 2016-09-01 Air Products And Chemicals, Inc. Personal care compositions containing functionalized polymers
US20070286838A1 (en) 2006-06-09 2007-12-13 T.F.H. Publications, Inc. Tamanu Oil Products
US7959905B2 (en) 2006-06-09 2011-06-14 T.F.H. Publications, Inc. Tamanu oil products
US8309109B2 (en) 2006-06-30 2012-11-13 Hakuto Co., Ltd. Cosmetic and method for production thereof
US8242169B2 (en) 2006-07-04 2012-08-14 Showa Denko K.K. Emulsion composition
US7759332B2 (en) 2006-08-04 2010-07-20 Glory F & D Co., Ltd. Cytotropic heterogeneous molecular lipids (CHML), method of preparation, and methods of treating patients with multiple cancers
EP2065030B1 (en) 2006-09-01 2015-11-04 Kao Corporation One-package hair dye composition
US7901465B2 (en) 2006-09-01 2011-03-08 Kao Corporation One-part hair dye composition
US8586111B2 (en) 2006-09-15 2013-11-19 Calvin Garris Method of applying a protective film over natural hair or scalp prior to application of bonding glue
US7832413B2 (en) 2006-10-27 2010-11-16 Goody Products, Inc. Therapeutic styling brush with infusion delivery
US7845360B2 (en) 2006-10-27 2010-12-07 Goody Products, Inc. Therapeutic styling brush with infusion delivery
US8562943B2 (en) 2006-11-08 2013-10-22 Novartis Ag Quality control methods for oil-in-water emulsions containing squalene
US9744231B2 (en) 2006-11-08 2017-08-29 Novartis Ag Quality control methods for oil-in-water emulsions containing squalene
EP2029170B1 (en) 2006-11-08 2009-10-28 Novartis AG Quality control methods for oil-in-water emulsions containing squalene
US8957112B2 (en) 2006-12-21 2015-02-17 Galderma Research & Development Cream gels comprising at least one retinoid and benzoyl peroxide
US20080175805A1 (en) 2007-01-19 2008-07-24 Guthy-Renker Corporation Cosmetic foundation
US20080175931A1 (en) 2007-01-19 2008-07-24 Nathalie Schlemer Cosmetic foundation
EP2120845B1 (en) 2007-02-21 2012-10-24 ROVI Cosmetics International GmbH Nanoparticles for use in cosmetic and dermatological formulations
US20080206371A1 (en) 2007-02-22 2008-08-28 Healing Skin Llc Novel burn treatment composition
EP2155888B1 (en) 2007-05-24 2014-07-09 Loders Croklaan B.V. Process for producing compositions comprising tocopherols and tocotrienols
US20080305057A1 (en) 2007-06-07 2008-12-11 Damage Control Technologies, Inc. New and improved skin treatment systems
EP2225003B1 (en) 2007-07-03 2017-10-11 L'Oréal Methods and kits for permanently coloring hair using persulfates, perborates or percarbonates
EP2179047B1 (en) 2007-08-10 2015-01-14 Bernd Fabry Lipophilic preparations
US20120321684A1 (en) 2007-09-07 2012-12-20 Guthy-Renker Llc Color Cosmetic
US8252298B2 (en) 2007-09-07 2012-08-28 Guthy-Ranker LLC et al. Color cosmetic
US20090074700A1 (en) 2007-09-14 2009-03-19 L'oreal Compositions and methods for imparting shine onto hair
US20090123398A1 (en) 2007-11-13 2009-05-14 Presperse, Inc. Silicon-free hydrocarbons providing aesthetic volatility
US20090130220A1 (en) 2007-11-20 2009-05-21 Johnson Pamela A Cosmetic composition having pomace olive oil
EP2214631B1 (en) 2007-12-05 2013-04-03 Henkel AG & Co. KGaA Hair shampoo having a surfactant/thickening combination
US9370570B2 (en) 2007-12-28 2016-06-21 Novartis Ag Polychlorinated biphenyls and squalene-containing adjuvants
US8628786B2 (en) 2007-12-28 2014-01-14 Novartis Ag Polychlorinated biphenyls and squalene-containing adjuvants
US8092813B1 (en) 2007-12-28 2012-01-10 Novartis Ag Polychlorinated biphenyls and squalene-containing adjuvants
EP2090296B1 (en) 2008-01-28 2017-03-15 Beiersdorf Aktiengesellschaft Application of agent complexes composed of panthenol, glycerin, citrate and/or bisabal oil against pollen allergy
US20090191136A1 (en) 2008-01-28 2009-07-30 Beiersdorf Ag Use of active substance complexes of panthenol, glycerol, citrate and/or bisabolol against pollen allergies
US20090226381A1 (en) 2008-02-11 2009-09-10 Sarah Maillefer Method and Composition for Reducing the Drying Time of Hair
EP2090295A1 (en) 2008-02-11 2009-08-19 Wella Aktiengesellschaft Method and composition for reducing the drying time of hair
US20080275118A1 (en) 2008-06-12 2008-11-06 Shaw Mari M Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
US8642659B2 (en) 2008-06-27 2014-02-04 Evonik Goldschmidt Gmbh Hair treatment product and hair after-treatment product containing ether guanidines as active substances, for protecting from damage caused by chemical treatment and for repairing already damaged hair
EP2145946B1 (en) 2008-07-16 2014-01-08 Daicel Chemical Industries, Ltd. Detergent Composition
US8088176B2 (en) 2008-08-29 2012-01-03 L'oreal Methods and kits for permanently coloring hair using a developer composition containing an oxidizer composition and a shampoo
WO2010023559A2 (en) 2008-08-29 2010-03-04 L'oreal Methods and kits for permanently coloring hair using a developer composition containing an oxidizer composition and a shampoo
US20110150810A1 (en) * 2008-09-05 2011-06-23 Kpss-Kao Professional Salon Services Gmbh Conditioning composition for hair
EP2218447A1 (en) 2008-11-04 2010-08-18 PharmaSol GmbH Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
US20120128777A1 (en) 2008-11-04 2012-05-24 Pharmasol Gmbh Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
EP2370052B1 (en) 2008-12-01 2017-08-23 BASF Beauty Care Solutions France SAS Novel sebum secretion inhibitory agent
US20110244063A1 (en) 2008-12-01 2011-10-06 Basf Beauty Care Solutions France S.A.S. Novel sebum secretion inhibitory agent
US20100143512A1 (en) 2008-12-01 2010-06-10 Basf Beauty Care Solutions France S.A.S. Novel sebum secretion inhibitory agent
US20130005774A1 (en) 2009-02-25 2013-01-03 Loupenok Leon Topical foam composition
CN101485622A (en) * 2009-03-03 2009-07-22 张嘉恒 Shampoo containing extract of Moringa oleifera and preparation method thereof
US9822243B2 (en) 2009-04-22 2017-11-21 Dr. Suwelack Skin & Health Care Ag Freeze-dried composition
US8871190B2 (en) 2009-04-25 2014-10-28 Sergeant's Pet Care Products, Inc. Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
US8911774B2 (en) 2009-05-18 2014-12-16 Cellhealth Technologies Ltd. Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use
US20150360183A1 (en) 2009-06-19 2015-12-17 Aquaporin A/S Biomimetic membranes and uses thereof
US20130277307A1 (en) 2009-06-19 2013-10-24 Aquaporin A/S Biomimetic membranes and uses thereof
US9463158B2 (en) 2009-06-24 2016-10-11 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010151240A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US20120189684A1 (en) 2009-07-17 2012-07-26 Reckitt Benckiser Healthcare International Limited Skincare Compositions
EP2528577B1 (en) 2009-07-17 2018-01-10 Reckitt Benckiser Healthcare International Limited Skin care composition for the treatment of acne vulgaris
US9155915B2 (en) 2009-07-27 2015-10-13 Dermadoctor, Inc. Moisturizing retinol composition
US20150157542A1 (en) 2009-08-12 2015-06-11 Colgate-Palmolive Company Oral care composition
US8906349B2 (en) 2009-08-12 2014-12-09 Colgate-Palmolive Company Oral care composition
EP2464328B1 (en) 2009-08-12 2016-03-30 Colgate-Palmolive Company Oral care composition comprising a sesquiterpenoid and an antimicrobial agent
EP2467120B1 (en) 2009-08-20 2017-05-24 Kneipp GmbH Composition for cleaning and/or caring for the skin, comprising an ethanolic and aqueous hydrodispersible mint composition
US7691792B1 (en) 2009-09-21 2010-04-06 Amyris Biotechnologies, Inc. Lubricant compositions
US20110112041A1 (en) 2009-10-01 2011-05-12 Baylor Research Institute Treatment of Male-Pattern Baldness by Local Induction of the Metabolic Defect of Fabry Disease
US20120219605A1 (en) 2009-11-05 2012-08-30 Peter Blackburn Adjuvanted nanoparticulate influenza vaccine
WO2011056226A1 (en) 2009-11-05 2011-05-12 Mercia Pharma Llc Adjuvanted nanoparticulate influenza vaccine
US8765158B2 (en) 2009-11-25 2014-07-01 Kao Corporation W/O emulsion cosmetic
US9180074B2 (en) 2009-11-25 2015-11-10 Kao Corporation O/W emulsion cosmetic
USRE46441E1 (en) 2009-12-03 2017-06-20 Novartis Ag Circulation of components during homogenization of emulsions
US8337870B2 (en) 2009-12-15 2012-12-25 Young Pharmaceuticals, Inc. Low toxicity topical active agent delivery system
EP2529726B1 (en) 2010-01-29 2015-06-03 Shiseido Company, Ltd. Oil-in-water emulsion sunscreen cosmetic composition
US20120283233A1 (en) 2010-02-05 2012-11-08 Paul David Gavin Carrier composition
US20160375136A1 (en) 2010-02-05 2016-12-29 Phosphagenics Limited Carrier composition
US20120316144A1 (en) 2010-02-25 2012-12-13 Hideo Minobe Antifungal agent
US20120201857A1 (en) 2010-03-17 2012-08-09 Pankaj Modi Transdermal delivery system for therapeutics
US8623330B2 (en) 2010-03-18 2014-01-07 Precision Dermatology, Inc. Emollient foams for treatment of seborrheic dermatitis
US20110256249A1 (en) 2010-04-16 2011-10-20 Doreen Campbell Hair and scalp care formulations for treating and preventing acne and related skin conditions
US8309143B2 (en) 2010-04-16 2012-11-13 Doreen Campbell Hair and scalp care formulations for treating and preventing acne and related skin conditions
US9539446B2 (en) 2010-05-14 2017-01-10 David J. Schenider Low chlorine odor control compositions
WO2011146837A1 (en) 2010-05-21 2011-11-24 Amyris, Inc. Squalane and isosqualane compositions and methods for preparing the same
US8586814B2 (en) 2010-05-21 2013-11-19 Amyris, Inc. Squalane and isosqualane compositions and methods for preparing the same
JP2011246361A (en) 2010-05-24 2011-12-08 Kao Corp Hair cosmetic
EP2392311B1 (en) 2010-06-01 2017-11-01 Intercos S.p.A. Process for obtaining a solid, compact powder cosmetic product.
US8529925B2 (en) 2010-06-09 2013-09-10 NY Derm, LLC Multi-active microtargeted anti-aging skin care cream polymer technology
WO2011162954A2 (en) 2010-06-09 2011-12-29 NY Derm LLC Multi-active microtargeted anti-aging skin cream polymer technology
US20110305737A1 (en) 2010-06-09 2011-12-15 NY Derm LLC Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology
US20130079395A1 (en) 2010-06-10 2013-03-28 Glaxosmithkline Biologicals S.A. Novel process
EP2589693B1 (en) 2010-06-29 2017-10-04 Kao Corporation Nanofiber
WO2012011904A1 (en) 2010-07-22 2012-01-26 The Procter & Gamble Company Methods for improving the appearance of hyperpigmented spot(s) using an extract of laminaria saccharina
US20120082629A1 (en) 2010-09-01 2012-04-05 Basf Se Associative Thickeners For Aqueous Preparations
JP2014500853A (en) 2010-10-05 2014-01-16 ルブリゾル アドバンスド マテリアルズ, インコーポレイテッド Acrylate copolymer thickener
US9931290B2 (en) 2010-10-05 2018-04-03 Lubrizol Advanced Materials, Inc. Acrylate copolymer thickeners
US8361520B2 (en) 2010-10-08 2013-01-29 Palmer Debbie M Antioxidant skin care compositions
US20120093755A1 (en) 2010-10-15 2012-04-19 Maneworx Inc. Compositions and methods for treating keratin based fibers
US8771658B2 (en) 2010-10-15 2014-07-08 Coolway Inc. Compositions and methods for treating keratin based fibers
JP2013539796A (en) 2010-10-15 2013-10-28 クールウェイ・インコーポレイテッド Compositions and methods for treating keratin-based fibers
US20170273899A1 (en) 2010-11-12 2017-09-28 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
US9642795B2 (en) 2010-11-12 2017-05-09 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
US9327021B2 (en) 2010-11-15 2016-05-03 Sanofi Pasteur Limited Immunogenic compositions
WO2012077120A2 (en) 2010-12-09 2012-06-14 Y&B Mother's Choice Ltd. Natural formulations
EP2650356A1 (en) 2010-12-09 2013-10-16 University of Tsukuba Novel microorganism having high squalene-producing ability, and method for producing squalene by means of same
US20140294921A1 (en) 2010-12-09 2014-10-02 Sigma-Tau Industrie Famaceutiche Riunite S.P.A. Composition for tipical use for treating skin disorders
US8476316B2 (en) 2010-12-15 2013-07-02 Olatec Industries Llc 3-methanesulfonylpropionitrile for treating inflammation and pain
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
WO2012092528A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US20140004176A1 (en) 2010-12-29 2014-01-02 Strategic Science & Techologies Delivery of treatments transdermally for fungal infections and other indications
US20140004177A1 (en) 2010-12-29 2014-01-02 Strategic Science & Technologies, Llc Cox-2 inhibitors and related compounds, and systems and methods for delivery thereof
US20140010866A1 (en) 2010-12-29 2014-01-09 Strategic Science & Technologies, Llc Methods and systems for treatment of migraines and other indications
WO2012109152A1 (en) 2011-02-07 2012-08-16 Professional Compounding Centers Of America, Ltd. Permeation enhancers for topical formulations
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
US20140037772A1 (en) * 2011-02-09 2014-02-06 Wendy Lien Cosmetic or Pharmaceutical Formulation
US9119974B2 (en) 2011-03-04 2015-09-01 Ahmed H. Al-Qahtani Skin cream
US9167839B1 (en) 2011-03-08 2015-10-27 Mark S. Bezzek Multivitamin-mineral regimens for longevity and wellness
US9789042B2 (en) 2011-03-25 2017-10-17 Kokyu Alcohol Kogyo Co., Ltd. Damaged hair improving agent and process for improving damaged hair using the same
US20120263660A1 (en) 2011-04-18 2012-10-18 Pop Test Cortisol Llc Hair Loss Treatment
US20120289590A1 (en) 2011-05-11 2012-11-15 Gerry Ritterman Hair cosmetic composition
US20130231317A1 (en) 2011-07-19 2013-09-05 Michael S. Riepl Dhea bioadhesive controlled release gel
US20140154200A1 (en) 2011-07-21 2014-06-05 Rhodia Operations Guar hydroxypropyltrimethylammonium chloride and uses thereof in hair treatment compositions
US8506938B2 (en) 2011-08-26 2013-08-13 Hsien-Wen Lin Compound applying to skin and a method making the same
US9446089B1 (en) 2011-09-20 2016-09-20 Aja Henderson Oil blend for skin treatment
US20130090279A1 (en) 2011-10-07 2013-04-11 The Procter & Gamble Company Shampoo Composition Containing a Gel Network
US9320744B2 (en) 2011-10-19 2016-04-26 Dhea Llc DHEA bioadhesive controlled release gel
WO2013065051A1 (en) 2011-11-01 2013-05-10 Naveh Pharma (1996) Ltd. Formulation and device for treating ceruminosis
US9295622B2 (en) 2011-12-06 2016-03-29 Mary Kay Inc. Substantive sunscreen formulation
EP2604298B1 (en) 2011-12-15 2016-03-30 DEMO SA Pharmaceutical Industry Multipurpose solutions for contact lens care comprising chamomile
US9849071B2 (en) 2011-12-19 2017-12-26 L'oreal Composition for the oxidation dyeing of keratin fibres, comprising particular fatty alcohols, a liquid fatty substance and a cationic polymer
US20150139929A1 (en) 2011-12-22 2015-05-21 Nicholas John Dixon Personal care composition and method of use thereof
EP2649986A2 (en) 2012-02-22 2013-10-16 Ignacio Umbert Millet Cosmetic composition for rejuvenating the skin and corresponding method and uses
US20130224268A1 (en) 2012-02-27 2013-08-29 Newgen Biopharma Corp. Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same
WO2013139812A1 (en) 2012-03-19 2013-09-26 Coty Germany Gmbh Cosmetic skin composition with soothing effect and its use
WO2013139808A1 (en) 2012-03-19 2013-09-26 Coty Germany Gmbh Cosmetic skin composition with soothing effect and its use
US9346722B2 (en) 2012-04-16 2016-05-24 Roquette Freres Method for refining squalene produced by microalgae
US8617579B2 (en) 2012-04-16 2013-12-31 Conopco, Inc. Pre-blended mixtures of specific naturally sourced liquid materials structured with naturally sourced high melting point structuring material
EP2839833A1 (en) 2012-04-20 2015-02-25 Biolab Sanus Farmacêutica Ltda. Topical pharmaceutical composition, method for producing the topical pharmaceutical composition, use of the topical pharmaceutical composition and method for the topical treatment of psoriasis, atopic dermatitis or chronic eczema
US20150079175A1 (en) 2012-04-20 2015-03-19 Biolab Sanus Farmacêutica Ltda. Topical Pharmaceutical Composition, Method for Producing the Topical Pharmaceutical Composition, Use of the Topical Pharmaceutical Composition and Method for the Topical Treatment of Psoriasis, Atopic Dermatitis or Chronic Eczema
EP2662074A1 (en) 2012-05-08 2013-11-13 Advanced BioNutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
US9101554B2 (en) 2012-05-17 2015-08-11 Eiji Sakuma Spray composition for companion animal bodies
US9303231B2 (en) 2012-05-29 2016-04-05 Roquette Freres Method for continuously enriching an oil produced by microalgae with ethyl esters of DHA
WO2014027370A1 (en) 2012-08-16 2014-02-20 Gencor Armats Biotek Pvt. Ltd Herbal preparation for stimulation of hair growth, control of hair fall, dandruff and infections thereof using ageratum spp.
EP2885004B1 (en) 2012-08-20 2016-10-19 Bionoox Suisse SA Composition comprising dihydroquercetin, alpha-tocopherol and bisabolol
US9271956B2 (en) 2012-08-20 2016-03-01 Bionoox Suisse Sa Companion cosmetic compositions
EP2700413B1 (en) 2012-08-20 2015-10-14 Bionoox Suisse SA Composition comprising dihydroquercetin, alpha-tocopherol and bisabolol
US20160008297A1 (en) 2012-08-23 2016-01-14 B.R.A.I.N. Biotechnology Research And Information Network Ag Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
US9399009B1 (en) 2012-10-05 2016-07-26 Clark Pharmaceuticals, Llc Composition and method of treating skin conditions
US9789099B2 (en) 2012-10-15 2017-10-17 Beiersdorf Ag Cosmetic or dermatological preparation for prophylaxis and/or treatment of atopic dermatitis
WO2014071354A1 (en) 2012-11-05 2014-05-08 Hercules Incorporated Composition comprising conditioning and/or styling polymer
US20170266099A1 (en) 2012-11-05 2017-09-21 Hercules Llc Composition comprising conditioning and/or styling polymer
WO2014076533A1 (en) 2012-11-19 2014-05-22 Vi.Rus Srl Unipersonale Composition of a cleansing foam based on natural extracts for the cleansing of the anal area
US9526681B2 (en) 2012-12-03 2016-12-27 Colgate-Palmolive Company Compositions and methods for treating dental caries
EP2925412B1 (en) 2012-12-03 2017-07-26 Colgate-Palmolive Company Compositions and methods for treating dental caries
US20150297504A1 (en) * 2012-12-11 2015-10-22 Jean-Marie Botto Cosmetic use of a carob seed extract as a slimming active agent
US20140186284A1 (en) 2012-12-27 2014-07-03 L'oreal Conditioning compositions for keratinous substrates
US20140187518A1 (en) 2012-12-28 2014-07-03 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
US8697043B1 (en) 2013-01-08 2014-04-15 Chattem, Inc. Odor suppression of volatile organic analgesic compounds and method of use
US20160206573A1 (en) 2013-03-01 2016-07-21 Envy Medical, Inc. Anti-Acne Formulation
WO2014134620A1 (en) 2013-03-01 2014-09-04 Envy Medical, Inc. Acne solution
EP2774601B1 (en) 2013-03-06 2017-08-16 Oleos Cosmetic and/or dermatological product made of cork extract, from at least one portion of the tree that provides cork, and at least one natural greasy substance, method for preparing same and composition containing same
US20140271940A1 (en) 2013-03-14 2014-09-18 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
WO2014149867A1 (en) 2013-03-15 2014-09-25 The Procter & Gamble Company Cosmetic compositions and methods for inhibiting melanin synthesis
WO2014152382A1 (en) 2013-03-15 2014-09-25 Strategic Science & Technologies, Llc Transdermal delivery of sildenafil and other phosphodiesterase type 5 inhibitors
US20140271949A1 (en) 2013-03-15 2014-09-18 The Iams Company Composition and Method for Preventing, Reducing, Alleviating or Treating Idiopathic Vomiting
US20140271506A1 (en) 2013-03-15 2014-09-18 The Procter & Gamble Company Cosmetic Compositions and Methods For Inhibiting Melanin Synthesis
US20150352022A1 (en) 2013-03-15 2015-12-10 The Procter & Gamble Company Cosmetic Compositions and Methods For Inhibiting Melanin Synthesis
US20160030553A1 (en) 2013-03-19 2016-02-04 Biotech Tools S.A. Allergen preparation
US20160067181A1 (en) 2013-03-19 2016-03-10 Senju Pharmaceutical Co., Ltd. Two-layer separation-type eye drop containing squalane
EP2977044A1 (en) 2013-03-19 2016-01-27 Senju Pharmaceutical Co., Ltd. Two-layer separation-type eye drop containing squalane
WO2014162280A1 (en) 2013-04-05 2014-10-09 Fuber Limited Emulsifying additive for forming emulsions of water in pure fuel oil or in mixtures containing mainly fuel oil and method for its production
US20140314911A1 (en) 2013-04-18 2014-10-23 Shandong Shenghai Health Care Products Co., Ltd. Deep-Sea Fish Oil Capsule and its Preparation Method
US20140350269A1 (en) 2013-04-29 2014-11-27 Glycerosolution Química Ltda. Acetals Esters Produced from Purified Glycerin for Use and Application as Emollients, Lubricants, Plasticizers, Solvents, Coalescents, Humectant, Polymerization Monomers, Additives to Biofuels
WO2014179520A1 (en) 2013-05-01 2014-11-06 The Procter & Gamble Company Cosmetic compositions and methods for inhibiting melanin synthesis
US9498420B2 (en) 2013-05-01 2016-11-22 The Procter & Gamble Company Cosmetic compositions and methods for inhibiting melanin synthesis
US20140348873A1 (en) 2013-05-22 2014-11-27 Professional Compounding Centers Of America Urea-Silicone Gel for Hyperkeratosis Treatment
WO2015030702A2 (en) 2013-08-26 2015-03-05 Keith Desanto High purity rhamnolipid cosmetic application
US20160200701A1 (en) 2013-08-30 2016-07-14 Inventure Renewables, Inc. Methods for the separation or purification of vitamin e, tocopherols and tocotrienols from lipid mixtures
EP2842607A1 (en) 2013-09-02 2015-03-04 Symrise AG A skin and/or hair whitening mixture
US20150064122A1 (en) 2013-09-02 2015-03-05 Symrise Ag Skin and/or hair whitening mixture
US20150080265A1 (en) 2013-09-18 2015-03-19 The Werc Shop, LLC Terpene-based compositions, processes, methodologies for creation and products thereby
US20150086522A1 (en) 2013-09-23 2015-03-26 Michael Todd True Organics Lp Formulation containing herb infused aloe
US8808759B1 (en) 2013-09-25 2014-08-19 Chattem, Inc Stabilized colloidal preparations, pre-mix and process for preparing skin care compositions, improved skin care composition, method for treating the skin
WO2015043931A1 (en) 2013-09-25 2015-04-02 Unilever Plc Method for evaluating the lubrication and/or friction of hair
US20160227776A1 (en) 2013-10-02 2016-08-11 Kyoyu Agri Co., Ltd. Composition containing attractant of noxious arthropod comprising plant-derived component and analogue of same
EP3031322A1 (en) 2013-10-02 2016-06-15 Kyoyu Agri Co. Ltd. Composition comprising harmful arthropod-attracting substance formed from plant-derived components and analogs thereof
US20150182447A1 (en) 2013-10-04 2015-07-02 Soung Lyul Park Method for improving skin condition comprising six steps and system therefor
US20160279073A1 (en) 2013-10-31 2016-09-29 Full Spectrum Laboratories, Ltd. Terpene and cannabinoid formulations
WO2015068052A2 (en) 2013-10-31 2015-05-14 Full Spectrum Laboratories, Ltd. Terpene and cannabinoid formulations
US20160287484A1 (en) 2013-11-15 2016-10-06 Emma Neame Dry Shampoo Composition for Hair
US9801900B2 (en) 2013-11-22 2017-10-31 Mary Kay Inc. Compositions for sensitive skin
WO2015074667A2 (en) 2013-11-25 2015-05-28 Unigroup Aps Composition for dermatitis
EP2878304A1 (en) 2013-11-26 2015-06-03 Aboca S.p.A. Societa' Agricola New fractions of chamomile extracts and uses thereof
WO2015083174A1 (en) 2013-12-08 2015-06-11 Y&B Mother's Choice Ltd. Preparations for suppressing or attenuating ocular irritancy
US20170020807A1 (en) 2013-12-08 2017-01-26 Y&B Mother's Choice Ltd. Preparations for suppressing or attenuating ocular irritancy
US20160316750A1 (en) 2013-12-17 2016-11-03 Simon Fraser University Compounds, Compositions and Methods for Attracting and/or Arresting Bed Bugs
US20150177221A1 (en) 2013-12-19 2015-06-25 L'oreal Simulated contaminated skin formulation
US20150174182A1 (en) 2013-12-20 2015-06-25 Pfizer Inc Pre moistened wipes for use in treating anal rectal irritations and disorders
US20160356798A1 (en) 2013-12-20 2016-12-08 Metabolon, Inc. Biomarkers of de novo lipogenesis and methods using the same
WO2015092609A1 (en) 2013-12-20 2015-06-25 Pfizer Inc. Pre-moistened wipes for use in treating anal-rectal irritations and disorders
US20160330957A1 (en) 2013-12-31 2016-11-17 Universidad De La Frontera Fungicidal composition for controlling phytopathogenic diseases, comprising a mixture of the volatile compounds ethanol, 3-methylbutanol, isobutyl acetate, isoamyl acetate and alpha-bisabolol; and the use thereof for inhibiting the growth of the pathogenic fungus botrytis cinerea
US20150182448A1 (en) 2013-12-31 2015-07-02 Shang Chen Mei Bang (Beijing) Biotechnology Co., Ltd. Traditional chinese medicine composition for dispelling wringles and black eye and its preparation method
US9056065B1 (en) 2014-01-27 2015-06-16 Shawnee Green-Tucker Hair composite
US9801796B2 (en) 2014-02-06 2017-10-31 Robertet S.A. Use of parfumery compounds against hair regrowth
US20170014314A1 (en) 2014-02-10 2017-01-19 Bbr Liquid cosmetic composition suitable for changing temporarily keratinic fibers color - related method
US20160367457A1 (en) 2014-02-13 2016-12-22 Basf Se Capryloyl alanine ethylester as a penetration enhancer
US20160374352A1 (en) 2014-03-10 2016-12-29 The Trustees Of Columbia University In The City Of Botanical antimicrobial compositions
WO2015138479A1 (en) 2014-03-10 2015-09-17 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
WO2015140138A1 (en) 2014-03-17 2015-09-24 Glaxosmithkline Biologicals Sa Oil/surfactant mixtures for self-emulsification
US20170080084A1 (en) 2014-03-17 2017-03-23 Glaxosmithkline Biologicals Sa Oil/surfactant mixtures for self-emulsification
US20150265526A1 (en) 2014-03-19 2015-09-24 Beaute Pacifique Aps Topical composition for the cosmetic treatment of the human skin
WO2015164433A1 (en) 2014-04-21 2015-10-29 Envy Medical, Inc. Acne solution
US9480634B2 (en) 2014-04-23 2016-11-01 The Procter & Gamble Company Cosmetic compositions
WO2015164290A1 (en) 2014-04-23 2015-10-29 The Procter & Gamble Company Cosmetic compositions having reduced irritation
WO2016178660A1 (en) 2014-05-02 2016-11-10 Hercules Inncorporated Personal care composition for a keratin substrate comprising conditioning and/or styling polymer
US20170266096A1 (en) 2014-05-02 2017-09-21 Hercules Llc Personal care composition for a keratin substrate comprising conditioning and/or styling polymer
WO2015175333A1 (en) 2014-05-16 2015-11-19 Restorsea, Llc Biphasic cosmetic
US9433564B2 (en) 2014-05-16 2016-09-06 Restorsea, Llc Biphasic cosmetic
EP3142633A1 (en) 2014-05-16 2017-03-22 Restorsea, LLC Biphasic cosmetic
EP3015114A1 (en) 2014-06-18 2016-05-04 Institute Of Process Engineering Chinese Acadamy Of Sciences Oil-in-water emulsion containing no surfactant and use thereof
US20160175432A1 (en) 2014-06-18 2016-06-23 Institute Of Process Engineering, Chinese Academy Of Sciences An oil-in-water emulsion containing no surfactant and use thereof
US20160000682A1 (en) 2014-07-02 2016-01-07 Geoffrey Brooks Consultants Llc Peptide-Based Compositions and Methods of Use
US20160151270A1 (en) 2014-07-02 2016-06-02 Geoffrey Brooks Consultants Llc Peptide-Based Compositions and Methods of Use
WO2016012757A1 (en) 2014-07-22 2016-01-28 Perachem Limited Hair conditioning compositions
WO2016012110A1 (en) 2014-07-22 2016-01-28 Bio.Lo.Ga. S.R.L. Composition comprising an ester of alpha-tocopherol for prevention and treatment of allergic rhinitis
WO2016012587A1 (en) 2014-07-25 2016-01-28 Biosynth S.R.L. Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
WO2016012797A1 (en) 2014-07-25 2016-01-28 Croda International Plc Anti-dandruff composition
WO2016018315A1 (en) 2014-07-30 2016-02-04 Younique, Llc Formulations, methods and devices for periorbital skin rejuvenation
EP3174519A1 (en) 2014-07-30 2017-06-07 Younique, LLC Formulations, methods and devices for periorbital skin rejuvenation
US20170231899A1 (en) 2014-07-30 2017-08-17 Younique, Llc Formulations, methods and devices for periorbital skin rejuvenation
US20170216368A1 (en) 2014-08-25 2017-08-03 Muciderm S.A. Pharmaceutical composition for preventing, treating, and curing psoriasis including snail slime, chamomile, and honey
EP3191074A1 (en) 2014-09-12 2017-07-19 The Procter and Gamble Company Cosmetic compositions and methods for inhibiting melanin synthesis
WO2016040757A1 (en) 2014-09-12 2016-03-17 The Procter & Gamble Company Cosmetic compositions and methods for inhibiting melanin synthesis
US9757317B2 (en) 2014-09-12 2017-09-12 The Procter & Gamble Company Cosmetic compositions and methods for inhibiting melanin synthesis
US20160081895A1 (en) 2014-09-18 2016-03-24 Stiefel Laboratories, Inc. Novel formulations
WO2016044374A1 (en) 2014-09-18 2016-03-24 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Novel formulations
US20170209383A1 (en) 2014-10-08 2017-07-27 Alva-Amco Pharmacal Companies, Inc. Composition for nap promotion
US20170281690A1 (en) 2014-10-10 2017-10-05 Muciderm S.A. Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, chamomile and propolis
US20170290799A1 (en) 2014-10-22 2017-10-12 Bio.Lo.Ga. S.R.L. Pharmaceutical composition for use in increasing the trophism of nasal mucosa
US9855346B2 (en) 2014-11-06 2018-01-02 Chang Gung University Of Science And Technology Fluorescent dye compositions and uses thereof
US9827176B2 (en) 2014-11-17 2017-11-28 Shirley Johnson Antifungal deodorant
US9295632B1 (en) 2014-12-17 2016-03-29 L'oreal Compositions comprising latex polymers and methods for altering the color of hair
US20160175238A1 (en) 2014-12-19 2016-06-23 L'oreal Hair cosmetic composition containing a polyurethane latex polymer and a silicone-organic polymer compound
WO2016112201A1 (en) 2015-01-07 2016-07-14 Strategic Science & Technologies, Llc Techniques and systems for transdermal delivery involving treatment of psoriasis, skin cancer, and other indications
US9782333B2 (en) 2015-01-21 2017-10-10 Chattem Inc. Oral composition for xerostomia
WO2016118907A1 (en) 2015-01-22 2016-07-28 Bcs Business Consulting Services Pte Ltd. Formulations of hydrophilic compounds
WO2016138505A1 (en) 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
WO2016144675A1 (en) 2015-03-06 2016-09-15 Medimmune, Llc Vaccine dose and use thereof
US20160317480A1 (en) 2015-04-28 2016-11-03 Nicholas Adam Brockman Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness
US20160324914A1 (en) 2015-05-05 2016-11-10 Tocol Pharmaceuticals, Llc Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation
US20160324754A1 (en) 2015-05-06 2016-11-10 Getco Llc Shave cream formulation
US20170216177A1 (en) 2015-05-18 2017-08-03 Angelo Perry Thrower Hair regrowth treatment and growth stimulant
WO2016196989A1 (en) 2015-06-03 2016-12-08 Senju Usa, Inc. Topical composition
US20170000707A1 (en) 2015-07-02 2017-01-05 Alfa Parf Group S.P.A. Method for Dyeing Keratin Fibres
WO2017034384A1 (en) 2015-08-24 2017-03-02 Rīgas Stradiņa Universitāte Epidermal lipid barrier restoring cream for facial skin, neck and decollete area for metabolic syndrome patients
WO2017037534A1 (en) 2015-09-06 2017-03-09 Prestigio Ltd. Topical compositions for treatment of psoriasis
US20170096418A1 (en) 2015-10-01 2017-04-06 Senomyx, Inc. Compounds useful as modulators of trpm8
WO2017059136A1 (en) 2015-10-02 2017-04-06 Amyris, Inc. Compositions containing bio-based farnesene or compounds derived therefrom and their use in consumer and industrial products
US20170128522A1 (en) 2015-10-14 2017-05-11 Paul Gavaris Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
WO2017068505A1 (en) 2015-10-20 2017-04-27 Codex V S.R.L. Non-saponifiable compounds from natural lipids for use in the treatment and the readjustment of the steroidal balance suffering from permanent chronic modification
US20170231895A1 (en) 2015-10-23 2017-08-17 C&C International Co., Ltd. Long-lasting powder essence composition with improved coloring and skin feeling and preparation method thereof
EP3159044A1 (en) 2015-10-23 2017-04-26 C&C International Co., Ltd. Long-lasting powder essence composition with improved coloring and skin feeling and preparation method thereof
US20170119658A1 (en) 2015-11-01 2017-05-04 Justin Turvey Preparation for enhanced fingerprint image formation on a transparent surface of a live scan device
US20170128355A1 (en) 2015-11-10 2017-05-11 Vincent C. Giampapa Topical composition for skin treatment to reduce lines and wrinkles of the face and body using a dual dna repair mechanism to address damage caused by aging and ultra-voilet induced damage to the skin with combination of skin turgor enhancement compounds
WO2017087924A1 (en) 2015-11-20 2017-05-26 Isp Investments Llc Personal care compositions comprising copolymers of cationic monomers and acryloyl lactam based monomers, process for the same and method of use
WO2017108902A1 (en) 2015-12-23 2017-06-29 Novartis Ag Oil-in-water emulsions including retinoic acid
WO2017161036A1 (en) 2016-03-14 2017-09-21 Isp Investments Llc Personal care composition for a keratin substrate comprising conditioning, color protecting and styling polymer
WO2017161387A1 (en) 2016-03-18 2017-09-21 Reid Christopher Brian Compositions of natural extracts and use thereof in methods for preventing or treating diseases
EP3231414A2 (en) 2016-03-21 2017-10-18 Cristiano Ravetta Spray dispenser device and composition for topical use comprising a c14 or c12 plant alkane
US20170281526A1 (en) 2016-03-31 2017-10-05 L'oreal Method for providing a customized skin care product to a customer
US20170281492A1 (en) 2016-03-31 2017-10-05 L'oreal Method and composition for treating skin conditions
WO2017204618A1 (en) 2016-05-23 2017-11-30 Attest Research Sdn Bhd A composition for preventing or mitigating dementia
US20170348203A1 (en) 2016-06-07 2017-12-07 Henkel Ag & Co. Kgaa Stable cosmetic cleansing compositions containing cold cream
US20170354585A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US9949915B2 (en) * 2016-06-10 2018-04-24 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US10159637B2 (en) * 2016-06-10 2018-12-25 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US10813872B2 (en) * 2016-06-10 2020-10-27 Clarity Cosmetics Inc. Hair and scalp formulations
US20170368376A1 (en) 2016-06-24 2017-12-28 Colgate-Palmolive Company Oral Care Compositions and Methods of Use
WO2018000060A1 (en) 2016-06-30 2018-01-04 L'oreal Anti-acne sunscreen composition

Non-Patent Citations (43)

* Cited by examiner, † Cited by third party
Title
A. Leone, A. Spada, A. Battezzati, A. Schiraldi, J. Aristil, S. Bertoli. "Moringa oleifera Seeds and Oil: Characteristics and Uses for Human Health." International Journal of Molecular Sciences, vol. 17, pp. 1-14, published Dec. 20, 2016. (Year: 2016). *
Alexis C. Perkins, et al., "Acne Vulgaris in Women: Prevalence Across the Life Span," 21 J Womens Health 223-230 (Feb. 2012), URL: http://online.liebertpub.com/toc/jwh/21/2, 9 pgs.
American Academy of Dermatology, Acne: Overview, https://www.aad.org/public/diseases/acne-and-rosacea/acne visited Jun. 6, 2016, 3 pgs.
Author Unknown. Skin Reference. Comedogenic Ratings (Causes Acne), http://skinreference.com/comedogenic-ratings-causes-acne/accessed May 31, 2018, 11 printed pages. (Year: 2018). *
BASF Lipofructyl MO LS 9305 Product Info Sheet [Moringa Oil], in one page, printed on Mar. 11, 2020.
BASF Puricare POE LS 9727 Product Info Sheet [Moringa Extract], in two pages, printed on Mar. 11, 2020.
Carly Cardellino, "13 Surprising Reasons You Keep Breaking Out," Cosmopolitan, published May 2, 2016, http://www.cosmopolitan.com/style-beauty/beauty/advice/a32686/surprising-things-that-cause-acne/, 12 pgs.
Christa Joanna Lee, "How to Get Rid of Forehead Acne," TeenVogue, published Jul. 12, 2016, URL: http://www.teenvogue.com/story/how-to-get-rid-of-forehead-acne, 4 pgs.
Database GNPD [Online] MINTEL Apr. 14, 2015, anonymous: "Oily-No Pore-Minimizing Elite Gel" XP055661592, retrieved from www.gnpd.com Database accession No. 3104805, abstract, ingredients; p. 2.
Database GNPD [Online] MINTEL; Dec. 20, 2011 anonymous: "Silver Clarifying Wash", XP055661596, retrieved from www.gnpd.com Database accession No. 1698667, abstract, ingredients; p. 3.
Database GNPD [Online] MINTEL; Jun. 22, 2015, anonymous: "Oil Balance Face Wash", XP055661772, retrieved from www.gnpd.com Database accession No. 3244397, abstract ingredients, p. 2.
Database GNPD [Online] MINTEL; Mar. 7, 2016, anonymous: "Special Acne Cream", XP055661608, retrieved from wwww.gnpd.com Database accession No. 3842049.
Database GNPD [Online] MINTEL; Oct. 17, 2012, anonymous: "Pimple Clearing Face Wash", XP055661780, retrieved from www.gnpd.com Database accession No. 1900083, abstract, ingredients; p. 2.
Database GNPD [Online], MINTEL; May 12, 2009 (May 12, 2009), anonymous: Conditioner, XP055661657, retrieved from www.gnpd.com Database accession No. 1105599, abstract, ingredients; p. 2.
Database GNPD [Online], MINTEL; Nov. 25, 2008 (Nov. 25, 2008), anonymous: "Treatment Deo Conditioner" XP055661664, retrieved from www.gnpd.com Database accession No. 1012579, abstract, ingredients, p. 2.
DATABASE GNPD MINTEL; "Conditioner", XP055661657, retrieved from https://www.gnpd.com/sinatra/recordpage/1105599/
DATABASE GNPD MINTEL; "Oil Balance Face Wash", XP055661772, retrieved from https://www.gnpd.com/sinatra/recordpage/3244397/
DATABASE GNPD MINTEL; "Oily-No Pore-Minimizing Elite Gel", XP055661592, retrieved from https://www.gnpd.com/sinatra/recordpage/3104805/
DATABASE GNPD MINTEL; "Pimple Clearing Face Wash", XP055661780, retrieved from https://www.gnpd.com/sinatra/recordpage/1900083/
DATABASE GNPD MINTEL; "Silver Clarifying Wash", XP055661596, retrieved from https://www.gnpd.com/sinatra/recordpage/1698667/
DATABASE GNPD MINTEL; "Special Acne Cream", XP055661608, retrieved from https://www.gnpd.com/sinatra/recordpage/3842049/
DATABASE GNPD MINTEL; "Treatment Deo Conditioner", XP055661664, retrieved from https://www.gnpd.com/sinatra/recordpage/1012579/
Emil A. Tanghetti, "The Role of Inflammation in the Pathology of Acne," 6 J Clinical and Aesthetic Dermatology, 27-35, Sep. 2013, 9 pgs.
English Translation of CN101485622A. "Shampoo containing extract of Moringa oleifera and preparation method thereof." Obtained from Google Translate on Aug. 21, 2020 at https://patents.google.com/patent/CN101485622A/en?oq=moringa+oleifera+seed+extract pp. 1-8, originally published 2009 in Chinese. (Year: 2009). *
Extended European Search Report for European Application No. 17811076.3, Date of Completion of Search Jan. 30, 2020, in 11 pages.
HerbalLocks.com. "The Top 5 Non-Comedogenic Shampoos." http://www.herballocks.com/natural-shampoos/top-5-non-comedogenic-shampoos/, accessed by examiner on Dec. 22, 2017, 10 printed pages. (Year: 2017).
HS Nahm. "Quality Characteristics of West African Shea Butter (Vitellaria paradoxa) and Approaches to Extend Shelf-life." Masters Thesis, Rutgers University, 2011. pp. title page, i-xii, and 1-121. (Year: 2011). *
Jaiswal, et al., "Effect of Moringa oleifera Lam. Leaves aqueous extract therapy on hyperglycemic rats", Journal of Ethnopharmacology, vol. 123, pp. 392-396, Year 2009.
James Q. Del Rosso, et al., "Status Report From the American Acne & Rosacea Society on Medical Management of Acne in Adult Women, Part 1: Overview, Clinical Characteristics, and Laboratory Evaluation," 96(4) Cutis 236-241, Oct. 2015, URL: http://www.cutis.com/uploads/media/media_1b35c69_CT096010236.PDF, 6 pgs.
Jamese . Fulton, Jr., "Comedogenicity and irritancy of commonly used ingredients in skin care products", j. Soc. Cosmet. Chem., 40, 321-333, Nov./Dec. 1989, 13 pgs.
Kali Borovic, "12 Hair Mistakes That Cause Acne & Sabotage Your Best Skincare Efforts," Bustle, published Mar. 5, 2016, URL: https://www.bustle.com/articles/146009-12-hair-mistakes-that-cause-acne-sabotage-your-best-skincare-efforts, 17 pgs.
Kristin Collins Jackson, "3 Paraben and Sulfate Free Shampoos, Serums, and Body Washes to go Natural With This Summer", article in bustle.com (http://www.bustle.com/articles/28720-3-paraben-and-sulfate-free-shampoos-serums-and-body-washes-to-go-natural-with-this-summer), Jun. 20, 2014, 7 pgs.
L Lanuza. "Sebamed Everyday Shampoo for Normal to Dry Hair and Scalp." http://www.projectvanity.com/projectvanity/2011/10/27/ sebamed-everyday-shampoo-for-normal-to-dry-hair-and-scalp.html, accessed Dec. 22, 2017, originally published Oct. 27, 2011, 8 printed pages. (Year: 2011).
Lauren Valenti, "The Sneaky Thing That's Making You Break Out . . . All Over," MarieClaire, published Mar. 10, 2016, http://www.marieclaire.com/beauty/news/a19207/hair-products-skin-breakouts/, 8 pgs.
Lexy Lebsack, "The Annoying Reason You May Be Breaking Out," Refinery29, published Jan. 9, 2016, URL: http://www.refinery29.com/hair-products-skin-break-outs, 16 pgs.
Lily Talakoub, "Smooth hair—an acne-causing epidemic," Dermatology News, published Apr. 19, 2016, URL: http://www.mdedge.com/edermatologynews/article/108161/acne/smooth-hair-acne-causing-epidemic, 4 pgs.
Mintel (Database GNPD [Online], Mintel; May 12, 2009 (May 12, 2009), anonymous: Conditioner, XP055661657, retrieved fromwww.gnpd.com Database accession No. 1105599, abstract, ingredients; p. 2 (Year: 2009). *
Nancy Janiczek-Dolphin, et al., "Can sebum reduction predict acne outcome?" 163(4) Br J Dermatol 683-8, Oct. 2010, URL: http//www.medscape.com/viewarticle/730258, 10 pgs.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority dated Sep. 12, 2017, in connection with corresponding international application No. PCT/US2017/036745 (12 pgs.).
Porespective, "Five Causes of Adult Acne That May Surprise You," Porespective, printed May 15, 2017, URL:https://www.porespective.com/five-causes-of-adult-acne-that-may-surprise-you/, 8 pgs.
Tash. "The complete List of Comedogenic Oils." Holistic Health Herbalist. Https://www.holistichealthherbalist.com/complete-list-of-comedogenic-oils/accessed May 30, 2018, pp. 1-136. (Year: 2018). *
Tina Ferraro, "Is Your Conditioner Causing You to Break Out?," TeenVogue, published Jul. 3, 2015, URL: http://www.teenvogue.com/story/hair-conditioner-causing-acne-breakouts, 4 pgs.
Valerie Tejeda, "Are Your Hair Products Making You Break Out?," TeenVogue, published Jul. 21, 2014, http://www.teenvogue.com/story/hair-products-cause-acne, 4 pgs.

Also Published As

Publication number Publication date
WO2017214497A1 (en) 2017-12-14
JP2019517592A (en) 2019-06-24
US20180235865A1 (en) 2018-08-23
EP3468530A1 (en) 2019-04-17
JP6992057B2 (en) 2022-01-13
US9949915B2 (en) 2018-04-24
CA3026108A1 (en) 2017-12-14
US10813872B2 (en) 2020-10-27
US10159637B2 (en) 2018-12-25
EP3468530A4 (en) 2020-03-11
US20200146964A1 (en) 2020-05-14
US20220079865A1 (en) 2022-03-17
US20190183775A1 (en) 2019-06-20
US20170354585A1 (en) 2017-12-14

Similar Documents

Publication Publication Date Title
US10813872B2 (en) Hair and scalp formulations
JP2002226386A (en) Composition for integument containing plant extract
JP6062538B2 (en) Compositions that provide shine and methods of use
WO2012042970A1 (en) Prophylactic or therapeutic agent for atopic dermatitis, and preparation for external application
US6977081B1 (en) Facial cream composition containing allantoin
EP3337444B1 (en) Synergistic conditioning and/or styling compositions comprising polyquaternium-37 and polyaptac
JPH11269043A (en) Cosmetic for scalp and hair
US10537507B2 (en) All-in-one skin brightening formulations specifically for pregnant subjects
US20220401353A1 (en) Personal Care Compositions and Methods for the Same
KR20040056079A (en) Cosmetic composition for preventing and therapeutic for a pimple
JPH11302133A (en) Cosmetic for scalp and hair
RU2722823C2 (en) Cosmetic composition for treating and preventing acne on skin
EP2346485B1 (en) Use of betaine
JPH11236319A (en) Composition for scalp and hair
KR100242858B1 (en) Hair shampoo composition for the treatment of itching or dandruff
JPS6322506A (en) External preparation for skin
JPH083042A (en) Dandruff preventing agent
JP4327989B2 (en) Hair cosmetics
JP2005325091A (en) External preparation composition
JPS62169717A (en) Hair cosmetic
Chester Afro products
KR20160068294A (en) Composition containing panasenoside for antibacterial
KR20160066171A (en) Composition containing icariside B2 for antibacterial
KR20160064705A (en) Composition containing icariside B6 for antibacterial
Chester Ethnic products

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

AS Assignment

Owner name: CLARITY COSMETICS, LLC, MARYLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RUBIN, IRIS;MAGED, GREGORY;GARRUTO, JOHN;AND OTHERS;REEL/FRAME:053823/0088

Effective date: 20170608

Owner name: CLARITY COSMETICS INC., MARYLAND

Free format text: CHANGE OF NAME;ASSIGNOR:CLARITY COSMETICS, LLC;REEL/FRAME:053823/0422

Effective date: 20160929

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE